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Dye-sensitized solar cellsBacterichlorins possess a characteristic intense electronic absorption in the near-infrared part of the elec-
tromagnetic radiation (NIR) from 700 nm up to 900 nm, where endogenous chromophores do not absorb
and which allows deep penetration through tissues. Although naturally-occurring metal complexes
derived from bacteriochlorophylls are unstable and their use is limited, it is currently possible to obtain
large-scale libraries of photostable synthetic compounds belonging to the bacteriochlorin family. This
review presents an up-to-date overview of the most significant studies on the synthesis, spectroscopic,
photochemical, and electrochemical characteristics as well as various potential applications of bacteri-
ochlorins and their metal complexes. Particular emphasis has been given to the possibilities of their
use in medicine, especially in photodynamic therapy of cancer (PDT), photodiagnosis (PD), and photody-
namic inactivation (PDI) of bacteria, viruses, and fungi. The combination of (metallo)bacteriochlorins
with polymeric micelles, lipoproteins, nanoparticles, and metal-organic frameworks in order to increase
their efficacy is also discussed. Other potential applications of (metallo)bacteriochlorins discussed in this
paper include their use as light-harvesting antennas, optical sensors, photocatalysts, and dye-sensitized
solar cells for efficient solar energy conversion.
 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CCBY license (http://
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The interaction of light with biologically active compounds
plays a key role in the living organisms’ function. Light energy is
a part of electromagnetic radiation that can lead to heating,
mechanical effects, and chemical reactions. Thus, the transfer of
energy through photon absorption results in a number of processes
and reactions essential for biology, industry, and medicine. More-
over, numerous medical strategies employ light to visualize the
interior of the body and are fundamental to its further application
in a variety of more sophisticated, modern diagnostic and thera-
peutic tools [1,2]. Therefore, the study of the light-driven processes
addresses issues of the most importance for both scientific
research and the quality of health care. The light absorption in tis-
sues is strongly dependent on the absorbed wavelength (kmax).
Ultraviolet (UV, 100–390 nm) absorbed by DNA, amino acids and
proteins, is more energetic electromagnetic radiation than visible
light (Vis, 390–720 nm) that, in turn, may be absorbed by endoge-
nous pigments such as hemoglobin, vitamins and other biologically
important molecules. Consequently, these forms of radiation do
not pass through the body (UV) or do not penetrate deep enough
into the tissues (Vis) [3]. On the other hand, near-infrared (NIR,
720–900 nm) is a low energy range of light where photons exhibit
a maximum depth of penetration through tissues. It is also worth
noting that the density of photon flux on the Earth’s surface
reaches a maximum at approximately 700 nm, and up to 40% of
VIS + NIR photons reaching the Earth’s surface are, in fact, NIR pho-
tons [4] (Fig. 1).NIR photons are the most penetrating and least hazardous to
human tissues and can, therefore, provide direct access to biologi-
cal targets. The range of spectra between 650 and 850 nm, where
light penetrates tissue up to 1–3 cm, has been termed as a pho-
totherapeutic window (Fig. 1). It is a low energetic part of the spec-
trum, where the compounds present in living tissues do not absorb
light, but it also corresponds to energies still sufficient for photo-
chemical reactions (e.g., generation of singlet oxygen through
direct energy transfer). Recent reports have demonstrated the
broad applications of NIR photons in photomedicine to facilitate
biostimulation [5], imaging [6,7], diagnosis [8], and therapy of
many diseases [9]. NIR photons are also extensively used in optical
communication and could potentially be the most energy-effective
in photocatalytic processes [4,10]. Unfortunately, their potential
has not been fully exploited for many years due to the lack of chro-
mophores, which by absorbing NIR radiation, would simultane-
ously be sufficiently (photo)stable. Thus, the synthesis of new
photo- and thermally-stable chromophores characterized by
intense absorption in the NIR is essential for their implementation
in solar energy conversion, photomedicine, sensing, and
photocatalysis.
Tetrapyrroles are a class of macrocyclic compounds that are
commonly found in nature and, by performing various biochemical
functions, are essential for the proper functioning of the majority
of living organisms [11–13]. They are present in many enzymes
and proteins whose functions include metabolism, transport of
molecular oxygen, as well as electron transfer and energy conver-
sion processes [11,13,14]. Moreover, they can be used as effective
Fig. 1. Scheme presenting the electronic absorption spectra of naturally-occurring tetrapyrrolic chromophores along with the highlighted region of the ‘‘phototherapeutic
window” and the interaction of light with human tissue.
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[15,16]. Tetrapyrroles are classified into three main classes: por-
phyrins, chlorins and bacteriochlorins. An example of a
porphyrin-based biologically active compound is heme present in
hemoglobin (Fig. 2, blue). The most studied chlorin-type molecule
is chlorophyll a (Chl a) responsible for the green color of plants,
algae, and cyanobacteria (Fig. 2, green). Whereas bacteriochloro-
phyll a (BChl a), involved in the photosynthesis in some bacteria,
belongs to the family of bacteriochlorins (Fig. 2, red). Although atFig. 2. Chemical structures of naturally-occurring chromopfirst glance, the difference between these macrocycles seems to
be insignificant, their spectroscopic, photophysical and redox
properties differ considerably, which will be discussed in detail
in this review. Unlike porphyrins, which possess a full tetrapyrrolic
system, chlorins have one reduced pyrrole, and bacteriochlorins
have two reduced pyrroles on the opposite side of the macrocycle
[17,18]. The chromophores presented in Fig. 2 are characterized by
strong absorption of UV-A radiation, weak absorption in the green-
orange region, and most notably, they possess an intense absorp-hores: heme, chlorophyll a and bacteriochlorophyll a.
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bacteriochlorins) range of electromagnetic radiation [18]. While
the results of research on the naturally-occurring macrocycles
are undoubtedly valuable and inspiring, the easy access to a large
amount of synthetic metallobacteriochlorins described in this
review offers a number of new opportunities for the investigation
of fundamental processes, fine-tuning of NIR optical properties,
and the search for a range of photochemistry-based applications.
To gain access to stable and efficient bacteriochlorins, several de
novo synthetic procedures have been recently developed [13,19].
Many of them afford bacteriochlorin with electron-withdrawing
substituents. For example, geminal dimethyl groups lead to the
stabilization of bacteriochlorin chromophore [20,21]. The other
modifications that protect bacteriochlorins from oxidation include
(i) insertion of appropriate metal ions into the macrocycle, (ii)
presence of exocyclic rings in the macrocycle, and (iii) introduction
of halogen atoms in themeso-tetraphenylbacteriochlorins [22]. The
core structures of synthetic bacteriochlorins are shown in Fig. 3.
Appropriate structural modifications enabled the synthesis of com-
pounds containing very diverse substituents in different positions
of the macrocyclic ring, which made it possible to obtain bacteri-
opyropheophorbides, bacteriopurpurinimides and tetraphenylbac-
teriochlorin derivatives, Fig. 3. There are also many N-fused
porphyrins [23] or derivatives annulated with conjugated rings
(e.g., anthracene [24]) as well as phthalocyanines [25,26] that
absorb in the far red or/and NIR spectral region [24,27]. Especially,
the strong NIR absorption of (metallo)bacteriochlorins is crucial for
light-harvesting and possible biomedical applications [28]. Many
authors reported the use of (metallo)bacteriochlorins that are cap-
able of mimicking bacteriochlorophylls, either as separate mole-
cules or as components of natural protein complexes [20,29]. The
other applications of bacteriochlorins include: (i) solar energy con-
version [30,31]; (ii) chemical or biological sensing [32–34]; (iii)
(photo)catalysis [35]; (iv) spectroscopic analysis and design of flu-
orescent probes [36]; (v) molecular imaging [37–39], (vi) optical
communication [40,41] and last but not least (vii) photodiagnosis
(PD) and (viii) photodynamic therapy (PDT) [42,43], Fig. 4.2. Basic photophysical processes, photochemical mechanisms
and reactive oxygen species (ROS) generation pathways
Redox reactions involving the electron transfer between donor
and acceptor molecules are the key processes determining the
effective course of photosynthesis. The reduction of molecular oxy-
gen by the photosystem I (PSI) in the Mehler reaction is a coupled
process that results in the creation of ATP without NADPH [44]. It is
therefore not unusual that ROS produced during photosynthesis
are redox and functioning signals as well as necessary regulators
of energy and metabolic fluxes [44–46]. In general, a photoactiveFig. 3. Molecular templates of semisyntheticmolecule (photosensitizer, PS), such as bacteriochlorophyll a, pos-
sesses a stable electronic configuration in the singlet ground state
(S0) with electrons having opposite spins located in the highest
occupied molecular orbital (HOMO). Following photon absorption,
an electron may be excited to the lowest unoccupied molecular
orbital (LUMO), resulting in the formation of the PS singlet excited
states (1PS*), Fig. 5.
Possible deactivation pathways of the PS excited states are illus-
trated in the modified Jabłoński diagram (Fig. 5). Higher PS vibra-
tional states decay in a non-radiative way by releasing of heat.
These fast processes (s ~ 1011–1014 s), include both vibrational
relaxation (VR) and internal conversion (IC). If the PS molecule
appears at the lowest vibrational level of the excited singlet elec-
tronic state, a spontaneous emission may occur. It leads to the
allowed transition to the singlet ground electronic state – S0. The
radiative process is called fluorescence and takes place in a
nanosecond time regime. According to the Stokes rule, the maxi-
mum of the fluorescence (S1-S0 transition) band is shifted towards
longer wavelengths with respect to the maximum of the absorp-
tion (S0-S1 transition) band. The transition of a PS molecule in
the singlet excited state (1PS*) to a triplet excited state (3PS*) is
not allowed due to the spin selection rule. However, it can be vio-
lated by spin-orbit coupling. If it happens, the spin reorientation
occurs, and the molecule is transferred to the metastable triplet
excited state (T1) as a result of the process called intersystem
crossing (ISC) [47]. Spin-orbit coupling usually occurs due to the
so-called heavy atom effect caused by the presence of various
metal ions, halogen and even oxygen atoms in the PS structure
[48]. Consequently, these structural changes affect photophysical
parameters such as the quantum yields of the intersystem crossing
(UISC), fluorescence (UF) and triplet state (UT) as well as the triplet
state lifetime (sT). 3PS* may either undergo phosphorescence (Ph)
or, more preferably, can react with substrate molecule (e.g., molec-
ular oxygen) in accordance with two main mechanisms of oxygen-
dependent photosensitization reactions. Type I photochemical
reaction includes an electron or a hydrogen transfer from a photo-
sensitizer in either singlet or triplet excited state to some substrate
molecules, wherease type II photochemical reaction involves direct
energy transfer from 3PS* to molecular oxygen in its triplet ground
state (3O2) resulting in the generation of highly reactive singlet
oxygen (1O2, 1Dg). Apart from these two basic mechanisms, there
are also some references to type III or even type IV mechanisms.
Those photosensitized reactions are independent of the molecular
oxygen concentration. Most generally, they involve activated PS
molecules and components of biological structures whose oxida-
tion leads to the formation of reactive organic radicals [18,49–
51]. However, the most controversial issue still remains mecha-
nism I. The process in which an electron transfer from the excited
photosensitizer to dioxygen leads to the generation of superoxide
radical ion (O2). However, some authors suggest that the oxidizedand synthetic bacteriochlorin derivatives.
Fig. 4. Possible modification and functionalization pathways of the (metallo)bacteriochlorins and their potential applications.
Fig. 5. Jabłoński diagram showing the possible photophysical processes, and photochemical mechanisms of ROS generation.
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mechanisms have been described in detail by us [18,48,51,53–56]
and by other authors [57–59], so they will be referred here only
very briefly. Typically, a superoxide ion radical (O2) is formed by
a one-electron reduction of molecular oxygen. In the discussed
photochemical processes, its formation is the result of the photoin-
duced electron transfer most likely from 3PS*. Superoxide ion is
quite a weak oxidizing agent in water. Nevertheless, in the subse-
quent step of oxygen reduction, hydrogen peroxide (H2O2) is
formed, which in turn in the presence of transition metal ions, in
particular Fe2+ and Cu2+, undergoes a Fenton reaction resulted in
hydroxyl radicals production [60]. Hydroxyl radical (OH), due to
its high standard reduction potential (2.31 V), is one of the most
powerful oxidants capable of reacting unselectively with the adja-
cent chemical compounds, including organic pollutants, biomole-
cules (proteins, DNA, lipids), and with almost any constituent of
cells [56]. Although the photosensitization under biological condi-
tions usually leads to a combined effect of both: type I and type II
processes, there are some factors more or less suitable for each of
them. Most frequently, the contribution of each individual mecha-
nism is affected by the type of PS, its concentration, type of solvent/
environment in which the reaction takes place, and the amount of
oxygen present in this environment. Low oxygen levels generally
favor type I reactions, while type II usually occurs at higher oxygen
concentrations [61].
The photophysical properties of naturally-occurring (bacterio)
chlorophylls make them well adapted to support the energy trans-
fer in photosynthesis. Unlike many endogenous pigments such as
carotenoids, they do not undergo thermal relaxation [45], and thus,
they can be maintained in the singlet excited state long enough for
electron transfer as well as charge separation. However, these
properties may create problems when light absorption exceeds
photosynthetic light utilization. When excitation energy is not
completely consumed during photosynthetic reactions, the life-
time of excited singlet state of bacteriochlorophyll (1BChl*)
increases in the light-harvesting antennae. This also enhances the
probability of the ISC, resulting in the creation of a bacteriochloro-
phyll molecule in the triplet excited state (3BChl*). It may cause a
significant increase in the generation of described above reactive
oxygen species: 1O2, O2, H2O2, and OH. Therefore, the dissipation
of thermal energy in bacteriochlorophyll systems can be under-
stood as a protective mechanism responsible for preventing the
formation of ROS instead of neutralizing them [45]. Nevertheless,
it should also be noted that oxygen species generation is often
associated with many beneficial effects. Moderate amounts of
ROS are present in living organisms to guarantee normal metabolic
functions and are involved in a number of signaling pathways in
cells. A slight increase in ROS concentration enhances cell prolifer-
ation and increases the probability of cell survival. However, an
excessive increase in their concentration can overcome the antiox-
idant capacity of cells and eventually lead to oxidative stress [62].
In normal cells, due to the presence of antioxidant enzymes, a
small amount of exogenous ROS does not lead to any toxic effects.
On the other hand, cancer cells, due to their dysfunctional meta-
bolic activity, maintain ROS levels at the toxicity threshold, thus
being in a permanent state of oxidative stress. An increase in
ROS concentration in cancer cells triggered by drugs, radiation,
photosensitizers, etc. may easily exceed their critical level, result-
ing in cell death. Thus, the fact that cancer cells are more sensitive
to exogenous ROS has been used in numerous therapeutic strate-
gies [63,64], including photodynamic therapy (PDT) and photody-
namic inactivation of microorganisms (PDI) [53,65]. These two
photochemistry-based modalities will be discussed in more detail
later in this manuscript.3. Photosensitizers based on the (metallo)bacteriochlorin
framework: design and synthesis
3.1. Naturally-occurring bacteriochlorophylls
3.1.1. Physicochemical and spectroscopic properties of
bacteriochlorophylls
The chlorophylls involved in plant photosynthesis and their
synthetic analogs are the most studied pigments in terms of spec-
troscopic and photophysical properties [9,66,67]. Certainly less
studied, probably due to their low stability, however essential for
understanding fundamental processes and possible applications
are bacteriochlorophylls (BChls) present in some photosynthetic
bacteria [9,68–72]. Compared to chlorophylls (dihydroporphyrins),
bacteriochlorophylls are tetrahydroporphyrins with two reduced
pyrroles placed on opposite sides of the macrocycle. The structures
of bacteriochlorophylls a-e are shown in Fig. 6 (bacteriochloro-
phylls f-g are misnamed) [9,73].
Both chlorophylls and bacteriochlorophylls contain Mg2+ as the
central metal ion. It is known that the metal insertion into the tet-
rapyrrole ring changes its electronic structure and photophysical
properties [75]. The progress in the reduction of pyrrole rings leads
to intense absorption in the NIR. Whereas chlorophyll a absorbs at
662 nm and chlorophyll b at 644 nm, bacteriochlorophylls a, b, and
g are characterized by strong absorption at 772 nm, 794 nm, and
762 nm, respectively [21]. Unfortunately, there are two major lim-
itations concerning bacteriochlorophylls: (i) instability, including
susceptibility toward adventitious dehydrogenation with the pos-
sible creation of the corresponding chlorin [72,76,77] and (ii) rigid
and complete substitution of the macrocycle that reduces the pos-
sible semisynthetic transformations [21,42,78].
In order to overcome these limitations, a number of modifica-
tions are possible, including the peripheral substitutions of the
macrocycle affecting their spectroscopic and photophysical prop-
erties. This modification results in a bathochromic shift of the
low energy absorption band (Q band) towards NIR, while maintain-
ing an appropriate energy level of excited states and lifetimes of
these states long enough to allow sufficient photochemical reac-
tions [79,80]. In that regard, synthetic chromophores have been
also used for electron-transfer and energy-transfer processes. Thus,
semisynthetic or synthetic bacteriochlorins can be an attractive
alternative to bacteriochlorophylls. However, naturally-occurring
bacteriochlorophylls still provide (Fig. 7) an excellent starting
material for further modification [81].
Compounds obtained from bacteriochlorophylls were coordi-
nated with several metal ions such as Zn2+, Cu2+, Pd2+, Co2+, Ni2+,
Mn2+, Cd2+, and Pt2+ [21,42,82,83] according to three main syn-
thetic pathways [28]. The first one involves the coordination of a
free macrocycle with Cd2+, followed by transmetalation. The other
modifications consist of the introduction of Mg2+ using a Grignard
reagent and direct reaction with salts of appropriate metals. The
insertion of metal ions into the macrocycles results in the signifi-
cant change of their electronic structure and optical properties.
These structural changes are particularly well described for por-
phyrins, for which an increase of symmetry from D2h to D4h is
expected. This change leads to the degeneration of LUMO and a
decrease in the number of Q bands in the electronic absorption
spectra from four to two bands. In addition, one can observe a dis-
tinct batho- or hypsochromic shift of the Soret band, depending on
the type of metal ion. Noteworthy, for Q bands, the introduction of
metal ions always leads to their displacement towards shorter
wavelengths [84–86]. For chlorins, however, no analogical changes
in the electronic absorption spectra are observed. The coordination
of metal ions does not influence the symmetry, but may cause a
Fig. 6. Chemical structures and electronic absorption spectra of various bacteriochlorophylls derived from anoxygenic photosynthetic prokaryotes: BChl a of Rhodobacter
sphaeroides; BChl b of Blastochloris viridis; BChl c of Chloroflexus aurantiacus; BChl d of Prosthecochloris vibrioformis and BChl e of Chlorobium phaeovibrioides. Adapted from [74].
Fig. 7. Schematic illustration of the bacteriochlorophyll a preparation via extraction from Rb. sphaeroides along with its electronic absorption spectra and its possible ways of
modification.
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the S0-S1 electronic transition. For example, chlorophyll a (Mg2+
chelated) possesses an absorption band at kmax = 662 nm, whereas
pheophytin a (free-base) absorbs at 667 nm in acetone [87]. Simi-
larly, in the case of bacteriochlorins, the introduction of metal ions
does not change the symmetry. Nevertheless, it leads to a batho-
chromic shift of the absorption band located in the red part of
the spectra. Therefore, bacteriochlorophyll a (Bchl a) absorbs lightat kmax = 772 nm, whereas bacteriopheophytin a (BPhe a) at
kmax = 749 nm in diethyl ether [87]. More importantly, metal
insertion significantly increases the molar absorption coefficient
determined for long-wavelength Q bands [71].
A series of bacteriochlorophyll derivatives were also studied to
determine the influence of the metal ions on the energy of
electronic transitions and their redox properties [71]. Table 1
summarizes the spectroscopic (absorption and emission) and
Table 1
Spectroscopic and electrochemical properties of natural and transmetalated bacteriochlorophyll derivatives [71,88,90].
Absorption




Compound By Bx Qx Qy E2ox E1ox E1red E2red
2H BPhe 362 (92.3) 389 (49.3) 532 (26.2) 754 (56.4) 759 0.57 0.29 1.26 1.66
Pd-BChl 334 (33.7) 388 (27.8) 535 (13.5) 763 (61.5) 764 0.52 0.23 1.23 1.66
Co-BChl 355 (40.6) 386 (27.5) 562 (10.2) 767 (56.3) –
Ni-BChl 366 (49.2) 391 (30.3) 598 (16.1) 771 (71.8) – 0.29 0.08 1.23 1.65
Cu-BChl 358 (44.7) 395 (31.9) 573 (12.2) 780 (56.1) – 0.36 0.08 1.27 1.65
Zn-BChl 364 (52.4) 390 (31.7) 579 (16.5) 773 (57.1) 782 0.35 0.00 1.42 1.76
Mg-BChl 374 (57.7) – 612 (16.9) 781 (76.0) 788
Cd-BChl 368 (65.6) 391 (44.1) 593 (19.4) 773 (69.6) 778 0.30 0.01 1.39 1.75
Mn-BChl 373 (64.4) – 601 (16.4) 780 (66.0) –
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complexes. As expected, the electronic absorption spectra of all
studied compounds reveal four characteristic absorption bands
(By, Bx, Qx, and Qy). All of the examined metal ions, but to a differ-
ent extent, affect the energy of electron transitions. The most
noticeable differences exsist in the energy corresponding to the
Qx and Qy bands, while smaller differences are observed in the Bx
and By bands. The most significant differences in the energy of
S0-S1 transitions were indicated for the BPhe complexes with
Cu2+, Mg2+, and Mn2+ metal ions. For these metal complexes, a
large bathochromic shift (approximately 30 nm) of the Qy bands
is observed [71,72,88,89].
The presence of metal ions in the macrocycle is crucial for the
proper functioning of many natural processes. In general, the dif-
ferences in the type of metal ion in the bacteriopheophorbide
may significantly change the photophysical and photochemical
properties. Magnesium derivatives (five or six coordination num-
ber) usually indicates the fluorescence quantum yield equal to
0.1, quite long singlet excited state lifetime (ss ~ 10 ns), and rela-
tively good quantum yield of intersystem crossing determined in
diethyl ether (UISC ~ 0.60 for Chl a and UISC ~ 0.76 for BChl a)
[84,89]. Zinc complexes (four or five-coordinate) are characterized
by much lower fluorescence quantum yield (UF ~ 0.03), a shorter
singlet excited state lifetime (ss ~ 2 ns), and a higher ISC quantum
yield [84]. These differences can be attributed to the heavy-atom
effect [91], which is even more pronounced for complexes with
heavier metals. For instance, the Pt-chlorophyll a triplet state life-
time determined in deoxygenated organic solvents is ten times
shorter than for free-base and Mg2+ and Zn2+ coordinated chloro-
phylls [90]. Palladium derivatives (four coordinate) are also charac-
terized by negligible fluorescence, the highest possible ISC
quantum yield (UISC ~ 1.00), and short triplet excited state lifetimes
[86].
Analyzing the influence of different metals on the photophysical
properties of bacteriochlorophylls, it can be assumed that the
choice of Mg2+ by nature and not Zn2+ (which more easily forms
complexes with tetrapyrroles), was not only motivated by the
greater bioavailability of magnesium, but also to protect the photo-
synthetic apparatus against the excessive generation of ROS. This
effect is quite different and more sophisticated for paramagnetic
metal complexes (e.g., Fe2+, Cu2+, Ni2+ and Co2+) with tetrapyrrolic
ligands than for Mg-derivatives. For such compounds, fluorescence
is not observed at all, and highly predominant internal conversion
can be detected. For instance, copper complexes with coordination
number 4 are characterized by very short singlet excited state life-
times, do not possess fluorescent properties, and, unlike other
derivatives, have other properties highly dependent on tempera-
ture [85]. Also, the choice of paramagnetic metal ions by nature
is considered as a protective mechanism against photochemical
reactions that can eventually lead to adverse effects. Nevertheless,
despite the lack of photochemical activity, this kind of metallopor-phyrins takes part in significant redox reactions and therefore par-
ticipate in various biochemical processes [88].
3.1.2. Bacteriochlorophylls in the bacterial reaction center
The bacterial reaction center (BRC) with densely packed pig-
ment molecules (e.g., chlorins and bacteriochlorins) surrounding
the protein matrix from photosynthetic purple bacteria is well
characterized in terms of their structure and spectroscopic proper-
ties [92,93]. The conversion through a network of well-
arrangement pigments into protein complexes is an ideal model
system for investigation of the structure- and function- relation-
ship due to the efficient energy transfer and charge separation.
Two-dimensional electronic spectroscopy (2DES) has emerged as
a powerful method appropriate for examination the electronic cou-
pling between chromophores [93]. The measurement of well
design sequences of three laser pulses with determined emission
frequency (t1, t2, t3) allows the capturing of dynamics with high
time resolution inside the system. This high resolution, nonlinear
optical spectroscopic method allows studying the chemical and
biochemical processes as well as interactions and dynamics of
complex molecular systems. For instance, the observation of the
light-harvesting antenna of photosynthetic microorganisms shows
strong pigment-pigment interactions by capturing energy flow on
a 2D frequency map, Fig. 8 [94].
Zigmantas et al. have studied light-harvesting complex LH3
from photosynthetic purple bacteria with B800–B820 bacteri-
ochlorins, which absorb in 800 nm and 820 nm, respectively
[92]. By using the 2D electronic spectroscopy, it was possible to
measure the different population times that reveal ultrafast molec-
ular dynamics within the B820 ring. Moreover, the asymmetry of
the 2D spectrum of highly symmetric structure LH3 with the cou-
plings between BChls eliminates cross-peaks by forbidding
selected electronic transitions. LH3 contains nine identical sub-
units with 27 bacteriochlorophyll molecules in the symmetric
ring-like light-harvesting structure. Closely packed 18 BChls of
B820 ring are strongly coupled, while nine rings of B800 are rela-
tively large separated subunits with exhibit weak intramolecular
coupling [92]. 2DES can be suitable for the molecules for which
the high-resolution crystal structure cannot be obtained. For
instance, Ginsberg et al. have studied the light-harvesting complex
4 (LH4) expressed by photosynthetic purple bacteria in the lack of
light with 2DES [95].
Nonlinear polarization-dependent spectra combined with theo-
retical modeling confirm the LH4 structure that consist of 8 identi-
cal protein subunits in an annular structure with a total of 32
molecules [96]. The significant efficiency of photosynthetic charge
separation involving bacteriochlorophylls has inspired many scien-
tists to recognize these processes at the molecular level. Konar
et al. have also examined the model of the bacterial reaction center
isolated from R. capsulatus (mutant with lack of ubiquinone). In
these studies, the strong interaction between pigments located
Fig. 8. 2D electronic spectroscopy (2DES) principle: 2DES records the signal which is emitted from a system (chromophores) after an interaction with a sequence of 3 laser
pulses with noncollinear geometry carrying information about the properties of the sample. 2DES of the BRC (PDB: 1K6L) which undergoes charge separation, involving the
energy-transfer and charge-separation processes with time and excitation frequency resolution. Measured 2D spectra are spread on so-called excitation and detection
frequencies and show correlations between different optical transitions in the system under investigation. Representative 2DES spectra adapted from [94].
Table 2
Theoretically calculated energies of HOMO/LUMO orbitals and energy gaps (eV)
compared with the experimental values of maximum wavelength (kmax) of the QX
absorption band for (metallo)bacteriochlorins.
Compound EHOMO/eV ELUMO/eV GAP/eV Qx kmax/nm
Mg-BC 4.83 3.68 1.15 778
Co-BC 4.86 3.69 1.17 767
Ni-BC 4.88 3.70 1.17 779
Cu-BC 4.89 3.73 1.16 780
Zn-BC 4.91 3.72 1.18 773
Ru-BC 4.92 3.58 1.34 –
Rh-BC 4.95 3.63 1.32 –
Pd-BC 4.92 3.67 1.25 –
Pt-BC 4.94 3.65 1.29 763
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ochlorophyll (BChl-A and BChl-2B), where an initially absorbed
energy derives from bacteriopheophytin (HA and HB) and then is
transferred to bacteriochlorophyll a (PA and PH) [94]. The energy
of couplings has been reported from the range ~400–750 cm1
for the special pair, to several cm1 between H and P and HA and
HB. Moreover, the excitation delocalization among the BRC is in
accordance with the energy transfer and charge separation mech-
anisms. These data resolve Qy/Qx cross-peaks of most weakly-
coupled BRC transitions with the two-color 2D spectroscopy [94].
The understanding of these naturally-occurring photosynthetic
systems with efficient energy conversion influences the develop-
ment of artificial light-harvesting devices.
3.1.3. Theoretical studies of bacteriochlorophylls properties
Parallel to experimental work, theoretical studies on the optical
properties of bacteriochlorophylls containing divalent metal ions
such as Co2+, Ni2+, Cu2+, Zn2+, Ru2+, Rh2+, Pd2+, and Pt2+ were con-
ducted. Particular emphasis was given to the derivatives contain-
ing metal ions, which have already been used in anticancer
therapy (for instance, Ru2+ and Pt2+). The main objective of these
studies was to combine the cytotoxic effect of these metals with
the spectroscopic properties of bacteriochlorophylls, enabling their
application as PDT-photosensitizers. The theoretical calculations
carried out using density functional theory (DFT) indicate that
the geometries of the selected bacteriochlorophylls reveal many
similarities [97]. The macrocycle is generally flat, and the intro-
duced metal ions are placed in the plane of the ring, indicating
the capability to insertion of metal ions with different sizes. Metal
ions are most strongly bound to nitrogen atoms, which are derived
from pyrrolic moiety. Based on the spectroscopic data present in
the literature, the optical properties of the examined systems were
also confirmed, Table 2 [97].
It was also concluded that all investigated complexes except
Mg-BChl and Zn-BChl are stable in aqueous solvents, which
enables their further investigation in biological systems. The mes-sage to be learned fom this study was that Ru-, Rh-, Pt- and Pd-
bacteriochlorophylls can be interesting photosensitizing agents
for future therapeutic purposes [97]. These predictions turned
out to be quite accurate because such types of compounds have
been successfully tested in vitro, in vivo and even clinically for
many years as potent photosensitizers for photodynamic therapy
(PDT), which will be discussed later.3.2. Semisynthetic derivatives of bacteriochlorophylls
3.2.1. Bacteriopyropheophorbides and bacteriopurpurinimides
According to the procedure mentioned earlier, it is possible to
convert the bacteriochlorophyll a extracted from Rb. sphaeroides
into bacteriopurpurin-18. Bacteriopurpurin-18 in the next reaction
steps is transformed into two types of bacteriochlorin derivatives:
bacteriopurpurinimide and bacteriopurpurin p6, which are respec-
tively equipped or not with a fused imide ring [98,99]. These types
of long-wavelengths (metallo)macrocycles were developed by R.K.
Pandey’s group. For instance, the synthesis and characterization of
a series of novel bacteriochlorins from 132-oxo-
bacteriopyropheophorbide as a starting material were reported.
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riopheophorbide derivatives from bacteriochlorophyll a [100].
The absorption spectra of these bacteriochlorins showed excep-
tionally large shifts of the Qy absorption band towards near-
infrared (kmax from 816 nm to 850 nm). Moreover, the determined
molar absorption coefficients for these low-energy bands also pos-
sessed remarkably high values, even up to 136 800 M1cm1. In
the following studies, the biological activity of these compounds
and some of the analogs was extensively investigated and their
excellent PDT efficacy against various types of cancer cells and
tumor models was proven [42,101].
In the same research group, a library of new compounds called
bacterioverdins was developed (Fig. 10). These molecules contain a
fused six-membered methoxy-substituted cyclohexenone (verdin)
as an isomeric mixture [100]. The most significant properties of
bacterioverdins include absorption at long wavelengths (865–
890 nm) and the favorable redox potentials that ensure both stabil-
ity and ROS generation ability, not necessarily through energy
transfer reaction. The comprehensive electrochemical studies were
conducted, which part of the results in the form of cyclic voltam-
mograms registered for each compound is demonstrated in
Fig. 11. The most interesting results of these studies include the
observation that three of the studied compounds, those with fused
cyclohexanone ring systems, show a remarkably smaller HOMO-
LUMO energy gap, and thus more readily undergo oxidation/reduc-
tion, compared to the previously investigated by authors bacteri-
ochlorins [102,103]. As already mentioned, the greatest
advantage of these compounds is their extraordinary absorption
in the NIR range, reaching wavelengths of nearly 900 nm. Hypo-
thetically, such compounds could be used in PDT to treat large,
subcutaneous tumor tissue, because photons in this range are able
to penetrate very deeply through tissues. Nevertheless, it should beFig. 9. Synthetic pathway for obtaining bacteriopheophorbide dnoted that absorption at such long wavelengths exceeds the range
specified for a phototherapeutic window (630–850 nm). This is
naturally related to the energy limitation in the generation of sin-
glet oxygen by such photosensitizers. However, appropriate redox
properties of this group of compounds may facilitate photoinduced
electron transfer reactions leading to the formation of oxygen-
centered radicals. Moreover, it seems that such compounds offer
a completely different application potential, e.g., for the construc-
tion of optical materials and information storage.
R.K. Pandey et al. have also reported the impact of the insertion
of metal ions, e.g., Zn2+, Cu2+, Sn2+, In3+ on the photodynamic activ-
ity of examined complexes [104]. To investigate the effect of these
metals on the photochemical properties, they prepared the corre-
sponding complexes based on the pyropheophorbide framework
(Fig. 12).
3.2.2. Pd-Bacteriopheophorbides
Compared to the corresponding free-based macrocycles, the
Pt2+ and Pd2+complexes are chemically more active and undergo
more efficient ISC to achieve higher values of the triplet excited
state quantum yields. Thus, combined with short excited-state life-
times, they mainly act as type I photosensitizers generating
oxygen-centered radicals in the biological environment [105].
The electronic absorption spectra of metallobacteriochlorins are
similar to free-base analogues but slightly shifted either to shorter
or more preferably longer wavelengths [106]. Most of the Pd-
bacteriochlorins photochemical properties make them valuable
for the application in PDT.
Palladium containing BChl a derivatives such as padoporfin
(Tookad, WST09) and padeliporfin (Tookad Soluble, WST11) pre-
sented in Fig. 13 are particularly interesting photosensitizers when
compared to their free-base analogues [107–110]. First of all, pal-erivatives from bacteriochlorophyll a as a starting material.
Fig. 10. The scheme to obtain bacterioverdins from 132- oxobacteriopyropheophorbide a; based on [100].
Fig. 11. Cyclic voltammograms of bacteriochlorin or bacterioverdin derivatives
registered in CH2Cl2 containing 0.1 M TBAP at the scan rate of 0.1 Vs1. Adapted
from [76].
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terized by nearly unity quantum yield of ISC. Besides, as has
already been demonstrated, bacteriochlorins coordinated with
Pd2+ have the most batochromically shifted long-wavelength
absorption band compared to other metal complexes. Pd2+ inser-
tion into BChls results in the UISC approaching 1 and an increased
phosphorescence quantum yield under anaerobic conditions. The
high value of UISC is in line with the short lifetime of the singlet
excited state. This brings the quantum yield of 1O2 equal to unity
(UD = 1) in organic solvents [111]. Nevertheless, the relatively
polar conditions (e.g., micelle/water solution) enhance the proba-
bility of charge-transfer processes between Pd-BChl a triplet state
and molecular oxygen [111]. Besides, the large NIR absorption,
desired redox properties and high value of UISC determined for
Pd-BChl derivative lead to a substantial formation of oxygen-
centered radicals upon a short irradiation time [111]. Studies on
the influence of human albumin (HSA) on the generation of ROS
by WST11 have shown that the photogenerated ROS are O2 and
OH radicals rather than singlet oxygen. This suggests that
WST11 photocatalyzed the electron transfer from PS associated
with HSA to the colliding oxygen molecules through several cycles
[105]. The obtained results may suggest that the resulting WST11-
HSA complex can be considered as a single reaction center, which
photocatalysis redox reactions required for the formation of ROS,
which are the appropriate cytotoxic agents in PDT [105]. The fol-
lowing research focused on palladium derivatives of BChl a led to
the development of photosensitizers possessing remarkable photo-
dynamic efficiency.
3.2.3. Zn-derivatives of bacteriochlorophylls
Semisynthetic and synthetic zinc complexes of bacteriochloro-
phyll a can be easily prepared by the replacement of the central
Mg2+ with Zn2+. Among the bacteriochlorophyll derivatives con-
taining metals other than Mg2+, only Zn-chlorophylls have chemi-
cal features quite comparable to Mg-chlorophylls [112,113].
Nevertheless, Zn-derivatives are more stable than Mg-derivatives
Fig. 12. Synthetic pathway for the synthesis of a series of (metallo)derivatives of methyl 132-oxo-pyropheophorbide a.
Fig. 13. Examples of Pd-bacteriochlorin derivatives: WST09 (padaporfin) and
WST11 (padeliporfin).
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[114,115]. Zinc-bacteriopheophytins (Zn-(B)Pheo) are known to
be good structural and functional models for naturally occurring
bacteriochlorophylls [116,117]. It was found that Zn-BPhe may
be used instead of BChl a in a special photosynthetic bacteria,
e.g., an Addiphilium rubrum [118]. Moreover, Zn-containing bacteri-
ochlorophyll has been introduced artificially into the isolated
antenna proteins as the replacement of light-harvesting Mg-BChl
or accessory Mg-BChl in the reaction center complex [70,113].
Yang and coworkers have synthesized and characterized the
series of zinc-bacteriochlorins with the different number ofelectron-withdrawing groups as peripheral substituents [29]. The
authors reported that their optical properties are not that different
from free-base bacteriochlorins and naturally-occurring bacteri-
ochlorophyll derivatives [118,119]. However, Zn2+ insertion into
macrocycle gives a lower fluorescence quantum yield (UF ~ 0.03),
a shorter singlet excited state (s ~ 2 ns), and a higher quantum
yields of ISC and triplet state when compared with metal-free com-
pounds [29]. Despite the lack of significant changes in the elec-
tronic absorption spectra, it should be recognized that for the
series of Zn-bacteriochlorin with the different number of
electron-withdrawing substituents, the differences in the values
of molar absorption coefficients are significant [21]. Moreover,
the zinc complexes are quite fluorescent, with quantum yields
ranging from 0.08 to 0.20 with an average value of UF = 0.13, which
is comparable to free-base analogs (UF ~ 0.15). The fluorescence
lifetimes are also similar to free-base analogs (3.3–4.4 ns) [29].
The quantum yield of intersystem crossing determined for the
Zn-bacteriochlorins (UISC = 0.7) is somewhat higher than the aver-
age value determined for free-base analogs (UISC = 0.5). This
increase is again attributed to the heavy atom effect [29,120]. In
conclusion, the synthetic zinc bacteriochlorins are characterized
by improved photostability and the photophysical properties
desired not only for medical applications but also for solar-
energy conversion, light-harvesting and catalysis [28,36–38,40].
Furthermore, they may also be applied in the development of con-
jugates and arrays designed with photosynthetic-like multipig-
ment architectures [35,117,121–124].
Fig. 14. Free-base and metal complexes of octaethyldioxoisobacteriochlorin.
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By changing the centrally coordinated metal ion in the bacteri-
ochlorophyll macrocycle, it is possible to modify various properties
not only in its ground but also in the excited states. It has been
shown that derivatives containing Ni2+ or Cu2+ ions undergo rapid,
nonirradiated conversion to the ground state without any photo-
chemical activity. The Stolzenberg group delineated the structural
and reductive chemistry of Pd2+ and Ni2+ octa-substituted bacteri-
ochlorin derivatives for biologically significant differences in ana-
log metalloporphyrins [125–127]. The synthesis of the Ni-
complexes (Fig. 14) was accomplished by isobacteriochlorin
metalations.
In the following studies, Lahiri and Stolzenberg have described
the possible mechanisms by which Ni+-octaethylisobacteriochlorin
anion can react with electrophiles [125]. They studied these pro-
cesses in the context of the relevance of Ni+ form in cofactor
F430, which is a Ni-containing prosthetic group of methyl coen-
zyme M reductase. This biologically-relevant enzyme catalyzes
the reductive cleavage of the thioether-cofactor in the final step
of methanogenesis. It also catalyzes the reductive dehalogenation
of chlorinated hydrocarbons by methanoic bacteria [125]. Ni-
substituted bacteriochlorophylls may also be applied in the con-
text of the light-harvesting antenna. For instance, Fiedor and
coworkers have reported that the replacement of the central
Mg2+ in chlorophylls by Ni2+ results in an ultrafast (up to femtosec-
onds) internal conversion, while maintaining the fundamental
optical properties in the ground state [128]. Another potential
application of these Ni2+ complexes could be their use in the future
as contrast agents for photoacoustic tomography.4. Synthetic (metallo)bacteriochlorins
Despite the unquestionable success of palladium-
bacteriopheoforbide, two main limitations of bacteriochlorophylls
are related to (i) their relatively low stability and photostability,
and (ii) the complete substitution pattern of the macrocycles, that
reduces the possibility of semisynthetic transformations [29]. Syn-
thetic bacteriochlorins offer an attractive alternative to semisyn-thetic derivatives of naturally occurring bacteriochlorophylls. The
well-known synthetic methods of obtaining (metallo)bacteriochlo-
rins include the hydrogenation and/or addition reactions (e.g., vic-
inal dihydroxylation) of suitable porphyrin or chlorin [20,29].
Nevertheless, these methods, depending on the existing substi-
tutes, could lead to the formation of regioisomers and leaves the
bacteriochlorin more prone to aerobic dehydrogenation [29].
The synthesis of the family of b-alkyl-substituted stable (met-
allo)bacteriochlorins was recently described. This procedure
implies the modification of the standard transmetalation proce-
dure using a strong base to protonate centrally placed –NH groups
and then adding the appropriate metal salt. The set of synthetic
bacteriochlorins bearing the different number of carbonyl groups
were testes under the following conditions: Zn2+ insertion to por-
phyrin ring and its further reaction in THF with a strong base upon
the use of proper metal salt. In such a way several metal complexes
can be obtained, namely: (i) derivatives with two aryl groups,
M = Cu2+, Zn2+, Pd2+, and InCl (but not Mg2+, Al3+, Ni2+, Sn2+, or
Au+); (ii) bacteriochlorins with two carboethoxy groups, M = Ni2+,
Cu2+, Zn2+, Pd2+, Cd2+, InCl, and Sn2+; and (iii) bacteriochlorins with
four carboethoxy groups coordinated with Mg2+ [21,29]. Compared
to free-base counterparts, these complexes are characterized by a
20–30 nm bathochromic shift of the low energy absorption Q band.
The theoretical calculations also indicated a decrease in the
HOMO-LUMO gap upon metalation [29]. It was shown that meta-
lation induced a slight distortion from the planarity and a shift in
the electron density on the frontier orbitals, particularly in the
LUMO level [29]. The fluorescence quantum yields (UF ~ 0.01–0.0
3) and singlet state lifetime (ss ~ 270 ps) of the metal complexes
were diminished by order of magnitude when compared to corre-
sponding free-base compounds. They also displayed a triplet state
quantum yield UT ~ 0.9 and a triplet state lifetime sT ~ 30 ls
[21,29]. The metal insertion also increases the heavy atom effect
by increased spin-orbit coupling, especially for the In-
bacteriochlorins presented in Fig. 15.
Another set of metallobacteriochlorins presented in Fig. 16 was
synthesized and thoroughly characterized by electrochemical mea-
surements and DFT calculations. Their most important spectro-
scopic, photophysical and redox properties, namely the
Fig. 15. Synthesis of Indium-bacteriochlorins during macrocycle formation.
Fig. 17. The chemical structures of synthetic bacteriochlorin (BC) and its dicyano-
(metallo)derivatives.
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yields of fluorescence and intersystem crossing (UF and UISC) as
well as HOMO and LUMO orbitals energies and oxidation poten-
tials, are summarized in Table 3.
The impact of metal insertion into bacteriochlorin macrocycle
was described in detail for dicyano Zn- and Pd-bacteriochlorins
and compared with their free-base analogs ((NC)2BC and BC,
respectively), Fig. 17. Each bacteriochlorin indicats a typical elec-
tronic absorption spectra. Both modifications (metallation and
introduction of cyano groups) lead to the noticeable shifts of the
low-energy absorption Qy bands. The absorption band registered
for metal-free dicyano-bacteriochlorin (NC)2BC in toluene is hyp-
sochromically shifted (35 nm) compared to the non-substituted
derivative [129]. The insertion of Pd2+ results in a slightly batho-
chromic shift to 751 nm, while the Zn2+ insertion causes an even
more significant shift up to 761 nm, Table 4.Fig. 16. Metallobacteriochlorins with a differen
Table 3
Photophysical, spectroscopic and electrochemical properties of metallobacteriochlorins w
Metal Number of with-drawing
groups
Absorption k(nm) Fluoresc
By Bx Qx Qy k (nm)
0 351 374 499 736 742
Free base 2 361 383 538 758 765
4 361 368 550 759 763
0 344 384 521 749 756
Zn 2 353 389 565 773 780
4 354 385 581 774 782
Cu 0 337 383 512 755 –
2 348 390 556 780 –
Pd 0 330 379 499 739 745
2 337 382 538 758 765
InCl 0 350 388 539 763 769
Mg 4 360 380 599 776 780Moreover, in comparison to BC, metallobacteriochlorins are sig-
nificantly less aggregated in water and are characterized by
enhanced photostability due to the presence of metal ion and
dicyano-substituents. BC, (NC)2BC and Zn2+ complex indicate com-
parable singlet excited state lifetimes (sS = 3.9–4.1 ns) and fluores-
cence quantum yields (UF = 0.14–0.15) determined in toluene and
methanol. Nevertheless, the fluorescence lifetime and quantum
yield of (NC)2BC-Pd are remarkably reduced (sS = 23 ps,
UF = 0.0008). The parameters determined for these complexes
are consistent with those determined for other Pd-
bacteriochlorophyll derivatives [111] and imidazolium metallo-
porphyrins [129,130]. The intersystem crossing quantum yield
determined for (NC)2BC-Pd reached unity, in contrast toUISC = 0.63
determined for (NC)2BC-Zn and 0.43 for (NC)2BC. The values ofUISC
obtained for unsubstituted BC (UISC = 0.62) clearly demonstrate the
influence of the cyano groups on the photophysical properties
[129]. Consequently, the triplet state lifetimes in deoxygenated
solutions are in the range from 80 ms to 170 ms for BC, (NC)2BC,t number of electron-withdrawing groups.
ith the different number of electron-withdrawing groups [20,21,29,129].
ence Triplet state Electrochemistry
sS ns UF UISC sT ls Eox Ered HOMO LUMO
3.3 0.18 0.55 163 +0.21 1.49 4.40 2.22
3.9 0.15 0.35 52 +0.38 1.29 4.65 2.48
4.3 0.16 0.24 46 +0.57 1.05 5.00 2.95
2.9 0.11 0.83 161 0.04 1.60 4.26 2.20
2.9 0.12 0.71 120 +0.45 1.38 4.55 2.51
4.4 0.13 0.80 38 +0.16 1.10 4.87 2.92
0.5 0.04 1.53 4.25 2.25
1.7 +0.18 1.32 4.53 2.55
0.35 0.02 >0.99 12 +0.43 1.14 4.36 2.26
0.015 0.006 >0.99 5.8 +0.29 1.29 4.63 2.54
0.21 0.016 0.9 44 +0.31 1.25 4.52 2.52
5.4 0.16 0.60 90 4.86 2.94
Table 4
Spectroscopic, photophysical, and redox properties of selected bacteriochlorins [129].
PS Absorption*; kmax/nm Fluorescence* Triplet Electrochemistry
By Bx Qy Qx kmax/nm UF sS/ns UT sT/ms Eox Ered HOMO-LUMO
BC 340 365 489 713 716 0.14 4.0 0.62 169 +0.09 1.67 2.25
(NC)2BC 347 372 515 748 752 0.15 4.1 0.43 84 +0.60 1.10 2.12
(NC)2BC-Zn 343 380 546 761 763 0.15 3.9 0.63 121 +0.31 1.14 2.01
(NC)2BC-Pd 326 374 518 751 753 0.0008 0.023 0.99 7 +0.52 1.03 2.05
*Determined in toluene.
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properties influence the ROS generation ability by these photosen-
sitizers. It is reported that the Pd-derivative produces a relatively
high amount of OH. The other compounds generate a smaller
amount of OH than 1O2 and are, therefore, less susceptible to type
I photoreactions. It is also demonstrated that the insertion of var-
ious metal ions influences the redox properties of studied photo-
sensitizers. The first oxidation potential (Eox) and higher
reduction potential (Ered) of the four bacteriochlorins [BC, (NC)2BC,
(NC)2BC-Zn, (NC)2BC-Pd] are summarized in Table 4. In general, the
introduction of the two cyano groups into bacteriochlorin core
results in the fact that the obtained derivative ((NC)2BC) is easier
to reduce and more difficult to oxidize than the molecule without
these substitutes (BC). Compared to free-base (NC)2BC, the palla-
dium derivative is slightly easier to oxidize and also slightly more
difficult to reduce. In contrast, the Zn2+ complex is significantly
easier to oxidize and, respectively, more difficult to reduce [129].
The importance of the redox potentials as factors influencing
the balance between type I and type II photochemical mechanisms
has been well established for dicyanibacteriochlorins and their
porphyrin analogs [51,131]. As mentioned above, Pd2+ complexes
of these tetrapyrroles are harder to oxidize and easier to reduce
(in a ground singlet and triplet states) than their Zn2+ counterparts
[129]. The redox properties of bacteriochlorins in the excited states
affect not only their physicochemical (e.g., photostability) but also
play the crucial role in the generation of reactive oxygen species
via either energy or electron transfer reactions. The photoactivity
of photosensitizers mediated by type I photoreactions may be par-
tially derived from the transient reduction of the macrocycle. Thus,
it is expected to be higher when photosensitizer undergoes a
reduction in its excited state. Nevertheless, photobleaching of pho-
tosensitizers [37,132] is mainly related to photooxidation (instead
of photoreduction) and photoaggregation (due to the p-cation rad-
ical formation). Thus, the photosensitizer, which is the hardest to
oxidize, is also the most stable compound [133]. The improved
photostability of photoactive compounds may be realized by intro-
ducing electron-withdrawing groups or coordination the central
metal ion (e.g., Pd2+) with high electronegativity into macrocycle
[20,21,49,134]. This, in general, make photosensitizer harder to
oxidize and easier to reduce. These statements may be supported
by the redox potentials as well as energies of molecular orbitals
determined theoretically in DFT calculation. Moreover, the molec-
ular substitution pattern enables to control and tune the HOMO
and LUMO energies, and redox potentials [20,135,136]. These rela-
tions were reported for the library of many synthetic photosensi-
tizers, including chlorins, bacteriochlorins and their derivatives
i.e. bacteriooxophorbines [38,111,137].
Recently, increased number of research reveals that type I pho-
toreactions with the formation of hydroxyl radicals, superoxide
and other oxygen-centered radical species play an important role
in the photoactivity of photosensitizers. For instance, WST09 and
WST11 are able to produce mainly superoxide anion and hydroxyl
radicals [105]. The contribution of the type I mechanism was also
determined for synthetic sulfonic and sulfonamide bacteriochlo-rins. It has been suggested that these bacteriochlorins may be
expected to generate ROS via both mechanisms, whereas por-
phyrins undergo mainly energy transfer with the formation of sin-
glet oxygen and they are in particular harder to oxidize than their
reduced derivatives [129].
The pallet of metallobacteriochlorins described in this part
(Fig. 18) [21,29] will be discussed in the following sections in the
context of their applications such as photodynamic therapy and
photodynamic inactivation. The analysis of Fig. 18 suggests that
from the synthetic point of view: (i) the unsubstituted bacteri-
ochlorins without any electron-withdrawing groups indicate a lim-
ited possibility to obtain the metal complexes through reaction
with a strong base; (ii) similar strong-base conditions can be
applied for a broader scope of metals using bacteriochlorin bearing
two carboethoxy substituents; (iii) for bacteriochlorins bearing
carboethoxy or imide 2–4 substituents, the Zn2+ can be inserted
according to the standard porphyrin metalation procedure; (iv)
for the derivatives bearing two carboethoxy substituents, reaction
in the presence of strong bases allowed faster metalation process
than the method involving the treatment with metal salt; (v) bac-
teriochlorin with 4 carboethoxy substituents gives the unstable Mg
chelate under the strong base conditions; (vi) ortho-aryl sub-
stituents are known to significantly slow down the metalation of
meso-tetraarylporphyrins [21].4.1. Theoretical studies of synthetic bacteriochlorins with transition
metal complexes
Parallel to experimental work, theoretical studies on the optical
properties of bacteriochlorins and their metal complexes are also
undertaken. L. Petit with collaborators performed theoretical cal-
culations for a family of metallobacteriochlorins containing diva-
lent transition metals including Mg2+, Zn2+, Mn2+, Fe2+, Co2+, Ni2+,
and Cu2+. DFT and TDDFT were applied to study electronic proper-
ties and structural changes. Fig. 19 presents the energies of orbitals
for each metallobacteriochlorin and the corresponding orbitals for
free-base bacteriochlorin (FBBC). Interestingly, although the
energy of the HOMO-LUMO gap was lower than the energy esti-
mated for the isolated ligand, no dramatic changes are observed
in comparison to FBBC. The presence of metal ions has little effect
on the relaxation of FBBC degeneration according to the interaction
with the ligand [138]. Solvent effects included in these calculations
by the implementation of the polarizable continuum model (PCM)
clearly indicate that both water molecules are coordinated with
the central metal ion. Unlike to evolution ion radius, the deter-
mined values are a bit reduced in the transition from Mn2+ to
Ni2+, and then they come back to Zn2+. It may suggest that stronger
adhesive interaction for metal than Fe2+ to Ni2+ concerning Mn2+,
Cu2+, and Zn2+. These calculations also revealed that Zn2+ is charac-
terized by the lowest interaction with the ligand, while Ni2+ shows
the greatest effect. The studies show the strongest ion interactions
of the central metal with nitrogen for Fe2+, Co2+, and Ni2+, whereas
for atoms with half-filled (d5 Mn) or filled (d10 Zn) orbitals, weaker
Fig. 19. Theoretical calculation of orbital energy levels for (metallo)bacteriochlorin derivatives. Adapted from [138].
Fig. 18. The summary of the conditions for the metalation of synthetic bacteriochlorins. Adapted from [21].
16 B. Pucelik et al. / Coordination Chemistry Reviews 416 (2020) 213340interactions are observed. Special attention was paid to the less
energetic part of the spectra, Table 5.
The result of these calculations clearly shows that the metala-
tion causes red shift of Qx and blue shift Qy bands, while comparingTable 5
Calculated energies of electronic transitions (eV) along with oscillator strengths in parent
Compound Qx/eV Qy/eV
FBBC 2.10 (0.24) 2.57 (0.
Mn-BC 1.99 (0.25) 2.46 (0.
Fe-BC 2.05 (0.26) 2.62 (0.
Co-BC 2.04 (0.28) 2.66 (0.
Ni-BC 2.02 (0.26) 2.65 (0.
Cu-BC 2.05 (0.25) 2.58 (0.
Zn-BC 2.04 (0.27) 2.56 (0.to the free-base bacteriochlorin [139]. The intensity of electronic
transitions indicates a slight increase in the molar absorption coef-
ficients after the metalation of the free-base compound. All of
these metal complexes except the Fe2+ complex possess an energyhesis for FBBC bacteriochlorin and its metal complexes [138].
By/eV Bx/eV
05) 3.81 (1.14) 4.10 (1.11)
05) 3.49 (0.51) 3.94 (0.49)
01) 3.09 (0.15) 3.93 (0.63)
03) 3.72 (0.55) 3.83 (0.26)
03) 3.69 (0.61) 3.82 (0.10)
01) 3.57 (0.63) 3.77 (0.25)
04) 3.68 (0.18) 3.81 (0.88)
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biological conditions, so it can be presumed that these compounds
fulfill one of the key requirements for their use as potent PDT
photosensitizers.
4.2. Peripheral modification of synthetic bacteriochlorins
4.2.1. Halogenated sulfonated and sulfonamide derivatives
Recently, the library of de novo synthesized halogenated bacte-
riochlorins have been developed [140,141]. The preparation of
these compounds consists of the following steps: (i) the synthesis
of appropriate porphyrins by modified nitrobenzene method that
involves the condensation of pyrrole with the appropriate aromatic
aldehyde in the presence of nitrobenzene in acidic conditions; (ii)
chlorosulfonation of the obtained porphyrins; (iii) either hydroly-
sis or reaction with amines to obtain respectively: hydrophilic (sul-
fonated) or amphiphilic (sulfonamide) halogenated porphyrins;
(iv) diimide reduction of these porphyrins to bacteriochlorins;
the metalation with the desired metal ion (as an example, the
introduction of Mn2+ and Mn3+ is presented in the Section 4.2.2)
[22,141–143]. The first attempt to the synthesis of the halogenated
sulfonamide and sulfonated bacteriochlorins involved a modified
Whitlock method, including the use of toluene as a solvent and cat-Fig. 20. Scheme of the synthesis of halogenated bacteriochlorin dalyzed by a relevant organic base. In the following years, it was
possible to develop an alternative synthetic procedure in accor-
dance with the sustainable chemistry approach. This method is
based on obtaining compounds under solid-solid conditions, with-
out the use of any solvents. Its key advantages are: efficiency, sim-
plicity, low environmental impact and the ability to provide a
library of photostable NIR-absorbing dyes with various polarities
and characterized by favorable physicochemical properties and
enhanced biological performance [144]. The general scheme of
the synthesis of halogenated bacteriochlorins and their metal com-
plexes are presented in Fig. 20.
Fig. 21 shows the structure of selected compounds belonging to
this family, together with their electronic absorption spectra [145].
Modifications within the tetrapyrrolic ring lead to the significant
changes observed in their electronic structure. The typical free-
base porphyrin with D2h symmetry is distinguished by the pres-
ence of the intense absorption band in the blue part escribed as
the Soret band and additional four Q bands in the range of larger
wavelengths (500–700 nm) corresponding to transitions between
vibrational levels of much lower intensity. The change in the sym-
metry of the system caused by the metal ion insertion results in a
change in symmetry of the system to D4h, which results in the
reduction of the number of Q bands in the absorption spectra fromerivatives and the possible pathways of their modifications.
Fig. 21. Scheme illustarting the chemical structures of the studied fluorinated and
sulfonamide porphyrin, chlorin and bacteriochlorin, together with their HOMO and
LUMO energies and corresponding electronic absorption spectra.
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in dipole vectors between the HOMO-LUMO levels. The Soret band
is most often observed as one absorption band due to the slight
energy differences in the case of porphyrins. If the energy differ-
ences between the respective levels are significant, then the degen-
eration of the LUMO orbitals occurs, resulting in the splitting of the
Soret band (Fig. 21) [146,147]. The reduction of subsequent pyrrole
rings in the macrocycle results in the destabilization of the HOMO
level and the LUMO orbitals. With the increasing degree of reduc-
tion of the pyrrole rings, the energy of transition between the occu-
pied orbital a1u(p) and the unoccupied orbital egy(p*) increases,
whereas between the orbital a1u(p) and the unoccupied orbital
egx(p*) does not change. The effect of these modifications is mani-
fested in the decrease in the energy of the HOMO-LUMO transi-
tions following: porphyrins > chlorin > bacteriochlorins. The
decreased HOMO-LUMO energy gap is also correlated with the
redox properties of porphyrins, chlorins, and bacteriochlorins.Together with the degree of reduction, the HOMO level energy
increases, so that the susceptibility to oxidation changes in the fol-
lowing series: porphyrin < chlorin < bacteriochlorin (lowering the
oxidation potentials), without changing the reduction potential
[148].
Despite the favorable optical properties of bacteriochlorins
(kmax = 740–780 nm), their significant limitation was low stability,
susceptibility to oxidation, and, as a consequence, reduced possi-
bilities of ROS photogeneration. Therefore, one of the objectives
of the research discussed here was to apply desired modifications
within the macrocycle, resulting in the pallet of photostable NIR-
absorbing compounds, which through appropriate redox and pho-
tophysical properties shall generate a high amount of ROS accord-
ing to both types of photochemical reactions (type I and type II
mechanisms). The first possible modification consists of the intro-
duction of phenyl rings into the tetrapyrrolic system in the meso
positions, which act as steric hindrance, which ensures compounds
with greater stability and more amphiphilic character. The intro-
duction of halogen atoms (-F, -Cl) to the ortho position of the phe-
nyl rings leads to spin-orbital coupling, increasing the yield of the
intersystem crossing. Moreover, these electron-withdrawing
groups stabilize the macrocycle against its oxidation. Achieving
large values of the efficacy of the ISC process also creates the ability
to control the mechanisms of photosensitization, and thus the effi-
cacy and type of generated ROS. The parameter allowing to assess
the effectiveness of the spin-forbidden transition is the spin-orbital
coupling constant (f), which for the hydrogen atom is f = 0.24; in
the case of chlorine: f = 586, and for fluorine f = 269 [149]. It
appears that the presence of a chlorine atom allows achieving
two times higher heavy atom effect. Nevertheless, the introduction
of fluorine atoms into the structure of the tested compounds
allowed to obtain optimal photophysical properties (improved
photostability, generation of triplet states), while maintaining the
fluorescence capabilities facilitating biological experiments being
carried out (e.g., subcellular localization, studies of pharmacokinet-
ics and biodistribution [22,25,142,150–152]. The summary of
properties determined for the library of halogenated bacteriochlo-
rins is presented in Table 6.
In addition to the effect on the photophysical properties of the
studied molecules, the introduction of fluorine atoms into the
structure also plays an important role in pharmacological proper-
ties [153]. Fluorine exhibits high biocompatibility and is a wide-
spread pharmacologically active compound [151]. The greater
therapeutic efficacy of compounds containing fluorine atoms in
the structure compared to non-fluorinated compounds has been
described by other authors [150]. The next possible modification
of the new synthetic bacteriochlorins involves their functionaliza-
tion with sulfonic or sulfonamide groups as well as coordination
with certain metal ions [154]. Substitution of sulfonic and sulfon-
amide groups allows to control the hydrophobicity of molecules
and to increase their stability by the effect of steric protection
[54,140,142,155]. The introduction of substituents with higher
electron-receptor properties leads to increased hydrophobicity of
photosensitizer, which affects its interaction with biological mem-
branes [156,157]. Moreover, the presence of sulfonamides in the
bacteriochlorin structure results in a remarkable increase in the
selectivity towards cancer cells and tumors as well as photody-
namic efficacy due to the higher lipophilicity of such photosensitiz-
ers [158].
4.2.2. Manganese complexes of halogenated bacteriochlorins
Manganese(III)-porphyrins are characterized by catalytic reac-
tivity, the possibility of photoreduction to Mn2+ and suitability
for the use as photoacoustic (PA) references [159,160]. Moreover,
they may be used in the production of effective piezophotonic
materials [161]. The described in the literature extraordinary spec-
Table 6
Photophysical, spectroscopic, and electrochemical properties of halogenated bacteriochlorins.






















FBMet 741 62 745 0.129 3.6 200 2.4 0.63
F2B 744 140 745 0.068 3.8 0.81 216 2.6 0.48 –0.95 0.65
F2BOH 745 56 745 0.023 268 0.44 –0.93 0.55 0.70
F2BMet 743 140 746 0.138 3.0 0.65 216 2.2 0.43 –0.74 0.80
ClBOH 742 61 745 0.040 246 1.9 0.42
Cl2BOH 745 61 748 0.006 226 2.1 0.85
Cl2B 747 126 748 0.012 1 254 2.1 0.60
ClBEt 743 76 746 0.038 228 2.1 0.61
Cl2BEt 745 110 747 0.013 0.39
0.54
1 265 1.8 0.66 0.79 0.82
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encouraged the synthesis of novel Mn3+ and Mn2+ coplexes of halo-
genated sulfonamide bacteriochlorins. The subsequent steps of the
synthesis of these manganese complexes of halogenated
tetraphenylbacteriochlorin are illustrated in Fig. 22 [162].
The properties of the electronic states of the Mn-based com-
pounds are significantly different from free-base bacteriochlorins
or their complexes with diamagnetic metals, Fig. 23. It was
reported that the Mn3+ complexes reveal eight electronic transi-
tions between various electronic states, including both: (i) p->p*
transition, typical for bacteriochlorin and (ii) ligand-to-metal tran-
sitions. Among them, the transition corresponding to the strongFig. 22. The synthetic pathways leading to the preparation ofabsorption band at ~830 nm deserves particular attention. The
lowest-energy transitions involve direct excitation from the singlet
ground to triplet excited state (e.g., S0(p,p*)? T1(p,p*) transitions).
Nevertheless, the interaction of metal (d, d) orbitals and the orbi-
tals of the macrocycle (p,p*) is not as significant as observed for
manganese(III) porphyrins [163,164]. This smaller mixing of orbi-
tals diminishes the intensity of the CT transitions and increases
the triplet excited state lifetime. Interestingly, the bacteriochlorin
abbreviated (Cl)MnCl2BMet2, as for a paramagnetic metallopor-
phyrin derivative, is characterized by the relatively long lifetime
of the triplet excited state (sT ~ 570 ps) and a quite substantial
quantum yield of the triplet state (UT ~ 0.2). Hence, the applicabil-Mn2+ and Mn3+ chlorinated sulfonamide bacteriochlorins.
Fig. 23. Energy ordering of molecular orbitals (in D4h symmetry) of tetraphenylporphyrins, bacteriochlorins and their manganese(III) complexes. Adapted and modified from
[162].
Fig. 24. The chemical structures of morpholino- derivatives of bacteriochlorins
with one and two oxygen atoms in macrocycle.
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considered. However, the efficient internal conversion in this man-
ganese(III) bacteriochlorin and its quite intense absorption at
kmax = 829 nm (e ~ 50,000 M1cm1), where tissues are transpar-
ent indicate that this class of compounds can be suitable for
biomedical applications such as photothermal therapy or even
photoacoustic tomography [165].
4.2.3. Morpholino- and lactone-based bacteriochlorins
The conversion of pyrroline to morpholine moieties in near-
planar meso-tetraarylbacteriochlorins results in ruffled mono-
and bis-morpholinobacteriochlorins (Fig. 24) characterized by
broadened and bathochromically shifted electronic absorption
spectra. Observed changes in the optical properties have been
assigned to a combination of two independent factors: (i) dihedral
angle between morphine and pyrrole moiety and (ii) molecular
planarity [139]. Conformational changes characterize bacteriochlo-
rin derivatives containing one or two non-pyrrolic heterocycles
with oxygen atom into the framework. Nonplanar conformations
induced by peripheral substituents in porphyrin may cause red-
shift of Q band even up to 50 nm [166]. The pyrrole reduction also
distorted the planar macrocycle, especially in two-reduced bacteri-
ochlorin, which increases ring flexibility. Insertion of oxygen in the
reduced domain with sp3 hybridization leads to even more
remarkable conformation changes than in free-base bacteriochlo-
rin. Nevertheless, the general trend between distortion and spec-
trum is red-shifted [167]. However, in some cases of structural
changes, morpholino- bacteriochlorins indicate blue-shifted Q
band caused by space-through interaction of electron-donating
oxygen with aryl groups.
Mazzone and co-authors have also provide computational stud-
ies on the morpholino-bacteriochlorins, which entails a distortionof the entire macrocycle derived from the insertion of the oxygen
atom between the two pyrrolidone carbons [168]. Computational
studies of the morpholino-derivatives with the introduction of a
different number of the phenyl group in the meso position also
show a notable effect on the conformation. Compared to
dihydroxy-dimethoxy bacteriochlorin, a bathochromic shift of
50 nm is observed for the morpholino-bacteriochlorin, which is
in line with spectroscopic experiments performed in solutions.
The crucial requirement for ideal photosensitizer is the energy
gap between the ground singlet and triplet excited state higher
than 0.98 eV adequate to the energy gap between triplet and sin-
glet oxygen. Considering the optical properties of these com-
pounds, including the HOMO-LUMO gap (Q band), as well as the
energy gap between the singlet-triplet excited state, the expanded
B. Pucelik et al. / Coordination Chemistry Reviews 416 (2020) 213340 21bacteriochlorins bearing morpholino groups can be proposed as
photosensitizers act via type II photochemical mechanism with
the singlet oxygen formation [168].
Nevertheless, the extension of the p-conjugation system may
cause undesirable changes in solubility (via p-p stacking), stability
and aggregation. Thus, the modulation of aromaticity in the tetra-
pyrrolic ring is a significant challenge, especially in reduced por-
phyrinoids. Another group of extended bacteriochlorin-like
compounds with a long-wavelength absorption in the NIR is repre-
sented by porpholactones. The introduction of an oxygen atom into
the macrocycle ring in b-peripheral position may extend p-system
without causing disadvantages mentioned above. Additionally, the
isomerization of b-oxazolone may tune the electronic ground
states, singlet and triplet excited states as well as the redox poten-
tials. The porpholactone derivatives are characterized by strong
absorption in the NIR, shifted similarly to naturally-occurring
hydroporphyrins. The introduction of the oxazolone group in the
macrocycle leads to, besides the p-system extension, lower sym-
metry (Cs) and stabilization of the HOMO and LUMO levels. The
isomerization may also significantly influence the photophysical
and photochemical properties of porpholactones. In this case, sim-
ilarly to naturally-occurring (bacterio)chlorophylls, cis/trans iso-
mers indicated the changes in the absorption spectra. Moreover,
it provides high efficiency in energy storage in photochemical pro-
cesses, e.g., mediated by cis-isomer of chlorophyll d derived from
cyanobacteria, which possess lower molar absorption coefficient
than chlorophyll a (non-isomeric). Moreover, compared to the Qy
absorption of chlorophyll d (cis-isomer), its trans-isomeric form
(chlorophyll f) indicates the stronger red-shift in the NIR (ca.
18 nm), Fig. 25 [169].
Zhang and coauthors have developed the novel synthesis
method of the porpholactone using desired ruthenium salt and
oxone. The oxidation of tetrapentafluorophenylporphyrin results
in porpholactone (F20TPPL, 85%) and porphodilactone (F20TPPDL,
15 %) derivatives with both trans- and cis- isomers [169]. It wasFig. 25. The influence of the orientation of b-substituents on NIR absorption of naturall
Adapted and modified from [170].also demonstrated that regioisomeric bacteriodilactone-based
derivatives with non-bonding electrons are more aromatic than
their typical bacteriochlorin analogs [96,171], with red-shifted of
Qy band (19 nm) and increased absorption comparable with
chlorophyll f and chlorophyll d [172]. Although porpholactones
indicate the similar optical properties to chlorophylls, their coordi-
nation capabilities are comparable with porphyrin derivatives. In
this respect, porpholactones and their metal complexes (Zn2+,
Pd2+, Pt2+, Fig. 26) [172] play an important role as a molecule for
many applications including photodynamic therapy, optical imag-
ing, and well as a novel sensing materials (see chapter 6). More-
over, they might be applied in catalysis, photocatalysis and even
electrocatalysis.
The regioisomerisation of metal complexes of porphodilactones
may also cause changes not only on absorption spectra but may
also alter the triplet excited states. For instance, trans-isomers of
Pd2+ and Pt2+ complexes showed red-shifted and longer-lived
phosphorescence than cis-analogs (Table 7) [170]. The discussed
porpholactones and their metal complexes might be applied as
small molecule activation catalysts and photo- or electrocatalysts.
Computational study of the ground and excited states for lactone-
based bacteriochlorin demonstrated the change of their stability as
well as has an impact on the absorption spectra [96]. The stabilities
and strong electronic influence of series regioisomeric porphodi-
lactone (Fig. 26) due to the charge delocalization, was also
reported.
5. Application of (metallo)bacteriochlorins in photodynamic
therapy (PDT)
5.1. Basic principles of PDT
Photodynamic Therapy (PDT) is a photochemistry-based medi-
cal strategy, dedicated mainly for cancer treatment, but recently
also widely used in the inactivation of localized bacterial infectionsy-occurring chlorophylls (Chl b, d, f) and porpholactones (cis- and trans-F20TPPDL).
Fig. 26. The structure of meso-C6F5-porpholactonebacteriochlorin (metallo)derivative and its possible regioisomers [96].
Table 7
Photophysical and electrochemical properties of the cis/trans porphyrinoids and their metal complexes [171,173].
PS isomer Absorption Emission Eox Ered DHOMO-
LUMO
B/nm Q/nm F/nm Ph/nm sPh/ls UPh 1st 1st 2nd exp calc
2H cis 408 505, 600, 657 662, 711 +1.66 0.44 0.85 2.10 2.45
trans 410 512, 551, 676 678, 755 +1.61 0.37 0.87 1.98 2.34
Pt cis 391 550, 562, 607 836 935 0.04 +1.60 0.54 0.92 2.14 2.49
trans 402 488, 525, 574, 623 866 1000 0.06 +1.59 0.45 0.99 2.04 2.41
Pd cis 411 514, 555, 568, 617 859 969 0.01 +1.58 0.50 0.94 2.08 2.45
trans 411 505, 543, 585, 638 916 1058 0.01 +1.56 0.41 0.94 1.97 2.34
Zn cis 423 532, 579, 634 640 +1.31 0.86 1.06 2.17 2.41
trans 422 536, 606, 662 670 +1.25 0.75 1.28 2.00 2.24
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chemical reactions: a photosensitizer (PS), a visible/near-infrared
light and molecular oxygen commonly present in the cells or tis-
sues. These components together result in the generation of highly
cytotoxic reactive oxygen species. Fig. 27 shows the subsequent
steps of the PDT procedure. The administered photosensitizer is
activated, and then undergoes several photophysical processes
and photochemical reactions. As discussed in Chapter 2, PS in the
triplet excited state is able to transfer an electron/hydrogen atom
or energy to another molecule, e.g., O2 to generate ROS. These spe-
cies are involved in the destruction of biological structures, leading
to oxidative stress within the tumor according to three related
anti-cancer mechanisms: (i) direct cytotoxic effect resulting in
apoptosis, necrosis and/or autophagy (cell self-healing process),
(ii) the indirect closure of tumor blood vessels, and (iii) stimulation
of the immune system to local and systemic responses, and induc-
tion of pro-inflammatory processes eventually leading to the
development of antitumor immunity [49].
The contribution of each mechanism depends on the applied
light dose, drug dose, drug-to-light interval (DLI), oxygen concen-
tration in the tumor tissue and applied irradiation margin [18].
The immune response against cancer cells is probably the most
important aspect of PDT because it creates the possibility of not
only destroying the primary tumor but also preventing the occur-
rence of metastases and finally taking a big part in the completecure of the disease [175,176]. On the other hand, the critical step
in the PDT studies is to develop a photosensitizer (PS) character-
ized by desired chemical and biological properties [132,177]. For
instance, it should indicate a strong absorption in the photothera-
peutic window, high values of UISC and UT, as well as long triplet
state lifetime [18].
Photogenerated ROS causes damage to biological structures at
the site of the PS localization, which consequently leads to tumor
destruction. An important issue is the determination of whether
and how the metal insertion or other substituents introduced
into the macrocyclic ring affect the ability to control photoin-
duced electron and energy transfer reactions
[55,154,157,178,179]. These studies are focused on the idea of
how modifications influence the ROS generation in cancer cells
[18,55,153,157,179,180], and improve their selectivity towards
diseased areas [178,181–184]. The most frequently studied
PDT-photosensitizers are tetrapyrrolic macrocycles, including
bacteriochlorins and metallobacteriochlorins [58]. Clinically used
photosensitizers, depending on their polarity, may either bind to
the plasma proteins (hydrophilic compounds) or accumulate in
different cellular compartments (compounds with higher
lipophilicity) [58,174,185]. In most cases, the cell nucleus is not
the primary target for photosensitizers, whereby PDT does not
induce genotoxic effects compared to classical chemotherapy
and radiotherapy [186,187].
Fig. 27. Principles of photodynamic therapy (PDT): photosensitizer (PS) is administered, and after a given drug-to-light interval (DLI), it is activated by visible or NIR light
leading to ROS generation that is responsible for various biological mechanisms and PDT activity.
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localization not only determines the appropriate choice of formu-
lation and incubation time but also allows to indicate the primary
site of photodamage [188]. For many years, singlet oxygen has
been considered the most important toxic agent responsible for
photoinduced cellular damage in PDT. Despite a relatively short
half-life, it is characterized by quite a large interaction range (its
activity reaches the radius of 20–550 nm) [189,190]. For compar-
ison, hydroxyl radicals generated according to type I mechanism
possess a radius of only 1 nm, but are more reactive than singlet
oxygen, which in turns is more selective oxidant. In the develop-
ment of new photosensitizers, besides the determination of physic-
ochemical and photochemical properties, pharmacokinetic studies
in vivo are essential to evaluate absorption, distribution, metabo-
lism, and excretion of potential drug candidates. The selectivity
of photosensitizers can be determined using tumor-to-skin (T/S)
and tumor-to-muscle (T/M) ratios. However, many features can
affect the tissue distribution and pharmacokinetic profile after
intravenous PS administration. The most critical of these are PS
charge, formulation and parameters of applied therapeutic proto-
col including drug dose, tumor model, drug-to-light interval
(DLI), administration route, light dose and type of the light source.
Thus, the direct comparison of the results obtained from different
laboratories is difficult and should be untertaken with coution
[191]. The pharmacokinetics and biodistribution largely determine
the choice of DLI [158,180,184]. The current state of knowledge
allows to distinguish three basic variants of protocols. The first
one is characterized by short DLI from 5 to 15 minutes and is
named vascular-targeted photodynamic therapy (V-PDT). The sec-
ond one (cellular-targeted photodynamic therapy, C-PDT) involves
the selective delivery of PS to cancer cells. For this protocol DLI
reaches >12 h, but usually involves 24 h, 72 h, or even 96 h from
PS administration to tumor irradiation. The last protocol is focused
on the targeting endothelial cells (endothelial cells-targeted photo-
dynamic therapy, E-PDT). It is characterized by an intermediate DLI
(usually 3 h) when the photosensitizer is found mainly in the blood
and endothelial cells with simultaneous accumulation in tumor
cells [153,180,192].5.2. Bacteriochlorin-based photosensitizers for PDT
5.2.1. Bacteriochlorophyll derivatives as naturally-occurring and
semisynthetic photosensitizers
Bacteriochlorophylls are characterized by stronger absorption
in the NIR than chlorophylls, which makes them theoretically more
suitable candidates for anticancer PDT [193]. However, naturally-
occurring Chls and BChls are not relevant for photomedicine
because they are not enough photostable. Moreover, they contain
a hydrophobic chain in the structure (phytyl), which hinders their
safe application and further localization in cancer cells. Neverthe-
less, through the use of structural modifications within the macro-
cyclic ring discussed in the Chapter 3, it is possible to increase their
application potential.
5.2.1.1. Bacteriochlorophylls as PDT sensitizers. Many bacteri-
ochlorophyll derivatives were tested both in in vitro and in vivo
conditions. The photoactivity of BChlide a and BChl-Ser was evalu-
ated in M2R mouse melanoma cells [194]. It was also reported that
BChl derivatives could be active even under hypoxic conditions,
acting mainly via type I photoreactions with hydroxyl radicals for-
mation [195]. Moreover, replacement of the Mg2+ with Pd2+ in BChl
structure significantly increased the photodynamic effect in vari-
ous cells, decreasing the LD50 value by order of magnitude without
any change in the dark toxicity [196]. BChl-Ser was applied as PS
against M2R melanoma and showed quite short elimination time
from the body (16 h), which prevents skin photosensitivity [194].
The optimized PDT protocol involved drug dose of 20 mg/kg BW,
light dose of 108 J/cm2, and tumor irradiation immediately after
PS administration. [197,198]. The described protocol, focused
mainly on the tumor vasculature disruption and blood flow stasis,
was characterized by significant efficacy, reaching over 80% cures
of mice [197]. The PDT activity was confirmed in other tumor mod-
els, for instance in SD sarcoma-bearing rats [199,200]. BChl-Ser-
mediated photodynamic efficacy was also tested in combination
with hyperthermia [199,200]. The tumor response to PDT with
BChl-Ser as photosensitizer was further controlled with a specific
intertissued oxygen microsensor. The rapid reduction of tumor
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duction during irradiation [201].
The first BChl-based compound,whichwas entered into the clin-
ical trials, was Pd-bacteriopheophorbide (padoporfin, Tookad,
WST09, see Fig. 13 and chapter 3.2.2) [202]. Vascular-targeted
PDT (V-PDT) with Tookad led to a significant therapeutic efficacy
against human prostate cancer as well as bone metastases. In the
discussed PDT protocol, NIR laser irradiation (k = 770 nm) with a
light dose of 90 J/cm2 was carried out immediately after intra-
venous PS administration at a dose of 4 mg/kg BW [109]. The ther-
apeutic efficacy of Tookadwas also verified towards prostate cancer
in dogs with the therapeutic regimen including NIR light irradiation
(kmax = 763 nm), light dose of 200 J/cm2 and a quite high drug dose
of 5 mg/kg BW [81]. Tookad-V-PDT was also effective in the treat-
ment of HT29 colon carcinoma (multidrug-resistant andwild types)
as well as C6 glioma tumors growing in mice [203–206]. WST09
(padoporfin) has proven to be a promising photosensitizer first in
preclinical [207], then in early clinical trials for PDT of prostate can-
cer [208,209] and was finally applied in clinics in 2004.
The data obtained from patients recruited to phase I suggested
that the skin photosensitivity related to V-PDT is negligible under
clinical protocol involving PS dose of 0.1–2 mg/kg and irradiation
(k = 763 nm) at ligh doses from 10 to 360 J/cm2 [210]. The drug
and light doses escalation studies were also performed in patients
with locally recurrent prostate tumors receiving external beam
radiotherapy (EBRT) and the tumor response were monitored with
Gd-enhanced MRI [208]. The phase I/II clinical trial conducted by
Gertner et al. indicated the safety as well as overall efficacy and
pharmacokinetic data of padoporfin-V-PDT [211]. The parallel tri-
als conducted by Arumainayagam et al. also involved the drug
and light dose escalating studies. The patients (Gleason score 7
and PSA <20 lg/L) were subjected to V-PDT with 2 mg/kg pado-
porfin administered in a 20 min i.v. infusion and irradiation with
763 nm diode laser (100–300 J/cm2). The optimal light dose able
to efficient tumor destruction was indicated as 200 J/cm2. More-
over, the short-term side effects that appeared on the urinary tract
were insignificant. Nevertheless, in one case, the cardiovascular
event and stroke were noted as an adverse result of hypotension.
It was supposed that these consequences are related to the pado-
porfin formulation containing Cremophor EL (CrEL), and thus the
clinical trial has been canceled [212].
Nevertheless, due to the high efficacy in PDT protocols directed
against tumor vasculature and positive results of phase I and II
clinical trials, padoporfin was replaced by the derivative with
higher hydrophilicity (padeliporfin, Tookad Soluble, WST11, see
Fig. 13) [105,110]. WST11 has a hydrophilic character that origi-
nated from the presence of negatively-charged -SO3H groups
[78,108,213]. The introduced modification ensures that this deriva-
tive does not require the use of any special delivery vehicles for its
intravenous administration. Tookad Soluble is capable of forming
the non-covalent complex with human serum albumin (HSA) after
intravenous administration. Thus, after injection, it can exist in two
forms (free-unbound and bound with HSA) and remain in the cir-
culation system, which can reduce the photodynamic treatment
directed to the tumor vasculature [105,214]. Nevertheless,
WST11 indicated the highest concentration in blood immediately
after i.v injection. During the time (up to 1 h) this concentration
increase in other tissue and finally the PS is eliminated from the
body [110]. Moreover, WST11 does not induce systemic toxicity
and its short life-time guarantees the rapid removal from the body
that also reduces the possibility of phototoxic side effects. In con-
trast to WST09, WST11 does not accumulate in endothelial cells,
and its photodynamic action is directed only toward blood vessels
[110]. The structural changes between WST09 and WST11, as wellas in their formulations, result in differences in their pharmacoki-
netic profiles and tissue distribution. WST09 indicated the high
activity in V-PDT due to maximal concentration in plasma achieved
after ca. 5 min and was eliminated from the body already after 3 h.
The effective concentration of WST09 in other organs, i.e., in the
liver and kidneys was initially high and then decreased over time.
These trends in tissue distribution, as well as body clearance, sug-
gest the undesirable binding to the RES system, which is character-
istic for hydrophobic drugs [215]. In consequence of short
circulation time in the body, PDT with Tookad Soluble requires
very short DLI. It should be highlighted, that both photosensitizers
(WST09, WST11) indicated no capacity to accumulation in tumor
and surrounding healthy tissue (skin or muscle). This effect pro-
vides their high selectivity towards tumor vasculature and tumor
microenvironment (extracellular milieu) [214,215].
The phase I/II clinical trials with water-soluble padeliporfin also
revealed its safety and tolerability in patients with prostate cancer
[216]. Azzouzi and coworkers have performed a comprehensive
analysis of data obtained in phase I/II (NCT00946881) and phase
II trials (NCT00707356, NCT00975429) from the patients (Gleason
score 7, PSA <10 lg/L) after V-PDT (4 mg/kg, 10 min i.v. infusion,
753 nm, 200 J/cm2) [217]. The primary outcome was long-term
negative biopsies determined in 68.4% of examined population
(>100) and 80.6% of patients received the hemiablation with light
density index (LDI, the parameter characterized the ratio of the
length of applied fiber optics in cm to the volume of treated area
expressed in mL) higher or equal to 1. Based on these results, it
was also indicated that in both groups, the prostate necrosis was
relatively high and PSA concentration decreased significantly
[203]. In phase II studies, the hemiablation in patients was also
observed during V-PDT with transperineally delivered radiation
[218]. In other studies, the necrotic area in ca. 90% of the treated
prostate tumors was detected using MRI. Moreover, V-PDT with
padeliporfin was presented as a highly tolerable and safe proce-
dure and the related adverse effects like prostatitis and other uri-
nary tract problems (e.g., haematuria) were reported only in
single cases [217]. During phase II investigation, the optimization
of V-PDT protocol was performed. For this reason, the men with
PSA <10 lg/L were subjected to the treatment and the most promi-
nent therapeutic outcome within the negative biopsy was
observed in 83 % of patients. Moreover, from the statistical point
of view, the average scores of the International Prostate Symptom
Score (IPSS), as well as the quality of patients’ life, indicated a sig-
nificant improvement with no further changes in the International
Index of Erectile Function score (IIEF-5). Moreover, it was demon-
strated that the patients treated with lower dose of padeliporfin
(2 mg/kg) revealed no significant therapeutic effect, while patients
subjected to a higher dose of PS (6 mg/kg) were characterized by
necrotic areas in surrounding organs [219]. Moreover, the histolog-
ical changes and long-term consequences examined 6 months after
V-PDT revealed relatively low adverse effects [220].
In the next step, Steba Biotech [221], as well as Azzouzi et al.
[223] have undertaken a multicenter phase II clinical trial to select
the optimal PDT conditions and estimate the safety and health-
related quality of life [222]. During II and III phases of clinical trials,
the standardized procedure of V-PDT mediated with padeliporfin
against prostate cancer was drawn up [204,217,223]. The efficacy
and feasibility of salvage radical prostatectomy (RP) after
padeliporfin-V-PDT was assessed based on the data from:
NCT00707356, NCT00975429 and NCT01310894, respectively. For
further evaluation of V-PDT against prostate cancer, the interven-
tional III phase of trials has been developed in the group of patients
recruited from Mexico, Panama and Peru. In the follow-up investi-
gation, the multicentre, randomized controlled and open-label
Table 8
The summary of clinical trials with padoporfin and padeliporfin in V-PDT against prostate cancer. Adapted and modified from [226].
Phase Patients PS PS dose [mg/kg] Irradiation Ref.
I 10 Padoporfin 0.1–2 763 nm,
100–360 J/cm2
[210]
I 24 Padoporfin 0.1–2 763 nm,
100, 230 and 360 J/cm2
[208]
I/II 15 Padoporfin 0.1–2 763 nm,
100 J/cm2
[211]
I/II 34 Padoporfin 2 763 nm,
100–300 J/cm2
[212]
I/II 30 Padeliporfin 2, 4, 6 753 nm,
100–200 J/cm2
[219]
II 28 Padoporfin 2 763 nm,
0.1–1000 J/cm2
[209]
II 40 Padeliporfin 2, 4, 6 753 nm,
200 J/cm2
[218]
II 40 Padeliporfin 2–6 753 nm, 200 J/cm2 [219]
II 85 Padeliporfin 4 753 nm,
200 J/cm2
[217]
II 56 Padeliporfin 4 753 nm,
200 J/cm2
[220]
II 86 Padeliporfin 4, 6 753 nm,
200 and 300 J/cm2
[224]
NCT00975429
II 117 Padeliporfin 4 753 nm,
200 J/cm2
[203]
II 40 Padeliporfin 2, 4, 6 753 nm,
200 J/cm2
[222]
II 40 Padeliporfin 2, 4, 6 753 nm,
200 and 300 J/cm2
[224] NCT00707356
II/III 86 Padeliporfin 4 753 nm,
200 J/cm2
[227]
II/III 16 Padoporfin 2 763 nm, no information about radiation fluence [224]
NCT00312442
II/III 1 Padeliporfin 4 753 nm,
200 J/cm2
[204]
II/III 19 Padeliporfin 4, 6 753 nm,
200 and 300 J/cm2
[228]
III 81 Padeliporfin 4 753 nm,
200 J/cm2
[224] NCT01875393
III 400 Padeliporfin 4 753 nm,
200 J/cm2
[224] NCT01310894
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padeliporfin-V-PDT with active surveillance in the prostate cancer
treatment [221,224,225]. The main characteristics of the described
clinical trials are summarized in Table 8.
Padeliporfin received EMA approval in 2017, is marketed in
Mexico and is under consideration by FDA. Finally, in November
2017, it was successfully approved for clinical practice in Mexico,
Israel, as well in the European Union (in 31 countries) and the
European Economic Area (EEA) [230]. Furthermore, besides early-
stage localized prostate cancer, padeliporfin is also being devel-
oped against other various types of tumors. In 2018 phase I clinical
trials in urogenital cancer (recurrent, second-line therapy or
greater, inoperable/unresectable) in the USA were started
(NCT03617003) and were launched for prostate cancer in the Uni-
ted Kingdom. Moreover, at the beginning of 2020, Steba Biotech
informed about planning a phase III clinical trial in prostate cancer
in USA (NCT04225299) [229].
Recently, V-PDT with WST11 is applied with the combination of
neoadjuvant or other treatment modalities. For instance, the possi-
bility of potentiation of antitumor response by V-PDT with PD-1/
PD-L1 immune checkpoint inhibition against melanoma was
described [230]. V-PDT was also combined with androgen depriva-
tion therapy (ADT), which is the most effective strategy for metas-
tases [231]. Moreover, it may be a promising strategy because
transcriptome profiling provided an upregulated androgen
response pathway following WST11-V-PDT [231]. Thus, it can be
hypothesized that targeting this pathway by a combination ofADT with V-PDT should be more effective compared to PDT or
ADT monotherapies [231].
5.2.1.2. 131-oxo-bacteriopyropheophorbide a derivatives. As men-
tioned in chapter 2.2.1., the modification of bacteriochlorophyll a
leads to bacteriopurpurins with increased stability. Pandey et al.
reported synthesis and characteristics of the series of alkyl ether
derivatives of bacteriopurpurin-18-N-alkylimides. Their photody-
namic efficacy was investigated in vitro and in vivo against the
radiation-induced fibrosarcoma (RIF) tumor model. The photother-
apeutic protocol consists of DLI = 24 h, drug dose of 0.2 mmol/kg,
intravenous administration of PS and irradiation with NIR light
(785 nm) with a total light dose of 135 J/cm2. It appeared that
the heptyl ether substituents with relatively high lipophilic charac-
ters are the most potent PDT photosensitizers resulting in 80%
cures of treated mice. All of the described data lead to the conclu-
sion that photosensitizers with longer alkyl ether carbon chain
indicate the highest PDT efficacy [98].
In other studies, 131-(4-aminobutylcarbamoyl)bacteriochlorin
methyl ether derivatives with different-length of aliphatic chains
were synthesized and characterized. These photosensitizers were
photodynamically active even at nanomolar concentrations against
various types of epithelial cells. Moreover, the in vivo studies per-
formed on S37 sarcoma tumor-bearing mice confirmed their
potential as PDT agents. The most significant therapeutic effect
was achieved after the application of 2.5 and 5 mg/kg BW drug
doses. After the application of the optimized PDT regimen, the
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mals followed up to ca. 4-months post-PDT was observed [213].
5.2.2. Synthetic bacteriochlorins as PDT photosensitizers
In contrast to naturally-occurring bacteriochlorophyll deriva-
tives, many PDT photosensitizers used in clinical practice are
hydrophilic or amphiphilic. A characteristic feature of hydrophilic
photosensitizers (>2 negative charges) is the lack of the ability to
penetrate biological membranes. They can accumulate in the cells
mainly via endocytosis or by photochemical internalization (PCI)
[232,233]. In many studies, it has also been shown that hydrophilic
photosensitizers (e.g., padeliporfin) [234,235] can accumulate in
lysosomes. Hydrophilic photosensitizers are easier to prepare in
aqueous solutions for their in vivo administration [177]. After
intravenous injection, they interact with plasma proteins, accumu-
late mainly in the tumor microenvironment and lead to significant
vascular effects.
5.2.2.1. Stable synthetic (metallo)bacteriochlorins. Lindsey and co-
workers described the library of synthetic, polarity-tunable bacte-
riochlorins containing positively-charged substituents. The biolog-
ical activity of some of these photosensitizers (Fig. 28, left) was
tested in vitro against, i.e., murine pigmented melanoma (B16 cells)
[236] and human cervical cancer cells (HeLa). Many of them have
demonstarted remarkable PDT efficacy at the low drug dose
(LD50 < 100 nM) [236–238].
The significant photodynamic activity of selected bacteriochlo-
rins may be related to their molecular design and substitution pat-
tern. The lipophilic character of these photosensitizers provides
their specific accumulation in critical organelles such as endoplas-
matic reticulum (ER) and mitochondria. Moreover, their spectro-
scopic and photophysical properties (discussed in detail in chapter
4), e.g., high molar absorption coefficient (~120,000 M1cm1),
determined for the NIR absorption band and the high triplet state
quantum yield make them very efficient against resistant cancers
including pigmented melanoma [236,237].
In the following studies, selected synthetic metallobacteriochlo-
rins including free-base unsubstituted bacteriochlorin (BC), its
dicyano-derivative (NC)2BC, as well as corresponding zinc
(NC)2BC–Zn and palladium (NC)2BC–Pd complexes were also
investigated in vitro against HeLa cells (see Fig. 17) [212]. The
photophysical and photochemical properties of these compounds
were described in chapter 4. The effect of dicyano peripheral sub-
stituents, central metal ion (Zn2+, Pd2+) and CrEL formulation on
the photodynamic activity was examined in biological conditions.
Their efficacy (DLI = 24 h, light dose = 10 J/cm2) may be arranged
in the following order: (NC)2BC-Pd > (NC)2BC > (NC)2BC–Zn  BC.Fig. 28. Synthetic (metallo)bacteriochlorin-based photosensitizers with modifica-
tion in 2, 3, 12, 13 position (left) and in meso position (right).Moreover, these bacteriochlorins indicate different subcellular
accumulation in organelles such as mitochondria, lysosomes and
ER. Noteworthily, the best efficacy of Pd2+ complex is most likely
related to damages of mitochondria and lysosomes caused mainly
by photogenerated hydroxyl radicals. These results confirm that
structural modification of bacteriochlorin-backbone via metal
insertion and introduction of electron-withdrawing substituents
(such as cyano moieties) provide a promising template for the
development of more active NIR-absorbing photosensitizers [239].
5.2.2.2. Halogenated sulfonic and sulfonamide bacteriochlorins. Prob-
ably the most versatile photosensitizers are amphiphilic com-
pounds – containing both hydrophilic and hydrophobic
substituents in their molecular structure [186,187]. They accumu-
late both in individual cell organelles, as well as membrane struc-
tures and intracellular space. Thus, they can be used either in
protocols targeting peritumoral vessels (V-PDT) or directed to can-
cer cells (C-PDT) [57,240,241]. Bacteriochlorins possessing halogen
atoms in the structure (chapter 3.2.1.) exhibit a low tendency to
aggregation, strong absorption in the phototherapeutic window,
enhanced stability and efficient formation of long-lived triplet
states. Furthermore, sulfonic/sulfonamide substituents allow the
control of the hydrophilicity/hydrophobicity balance and provide
additional protection against oxidation [22,54,142]. Halogenated
and sulfonamide bacteriochlorins have been successfully tested
against various types of cancer cells [154,157,180–182,184,242].
They have proven to be non-toxic in a wide concentration range
(0.001–50 mM), which make them potentially suitable for biomed-
ical applications. It has also been shown that studied photosensi-
tizers efficiently accumulate in cancer cells depending on the
molecular structure of PS, incubation time as well as cellular phe-
notype [54,178,243]. The time-dependent cellular uptake of chlori-
nated sulfonamide derivatives increased steadily over time and
reached a maximum after 18–20 h of incubation [158]. Similar
results were obtained for fluorinated sulfonamide bacteriochlorins,
while the more polar, negatively-charged sulfonated bacteriochlo-
rin (ClBOH) indicates a relatively low ability to accumulation in
cancer cells [243]. The cellular uptake of the studied compounds
seems to be facilitated by their well-balanced amphiphilic charac-
ter. Sulfonamide bacteriochlorins are uptaken by cancer cells in
amounts ten times higher than their sulfonated analogs [155].
Moreover, amphiphilic (sulfonamide) photosensitizers revealed a
high degree of localization in critical cellular targets such as ER
and mitochondria, whereas hydrophilic (sulfonated) compounds
were found mostly in the lysosomes. The photodynamic effect
mediated by these bacteriochlorins led to pronounced morpholog-
ical changes in cells integrity. Most of them can be related to the
hallmarks of apoptotic cell death, i.e., cells shrinkage and pyknosis
were visible by light microscopy [186,187,244]. Furthermore, it
was reported that fluorinated sulfonamide bacteriochlorin is able
to induce autophagy [245] and immunogenic cell death in vitro
[246,247]. Following photodynamic action with appropriate light
doses and in the presence of photosensitizers, complete inhibition
of cell proliferation can be assessed. For instance, the irradiation of
cancer cells with low-powered halogen lamp performed after 18–
20 h of incubation with sulfonamide bacteriochlorins leads to sig-
nificant inhibition of proliferation in all tested cell lines. For better
understanding the photodynamic activity and evaluating the effect
of the light fluence on cells viability (PS concentration with no tox-
icity in the absence of light), the S91/I3 and A549 cells were incu-
bated with photosensitizer at the desired concentration and then
irradiated with different light doses at 0.06; 0.16; 0.32 J/cm2. Fur-
thermore, the wide range of PS concentrations (1–10 mM) was
applied to evaluate the effect of the PS concentration on cells via-
bility. The representative results of these experimental conditions
examined for four tested bacteriochlorins are presented in
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tution pattern – the most effective photosensitizer is difluorinated
sulfonamide bacteriochlorin (F2BMet), in contrast to monochlori-
nated sulfonamide one, which exhibit the lowest efficiency (ClBEt).
In addition, there is no correlation between observed photody-
namic efficacy and, determined for each photosensitizer, singlet
oxygen quantum yields, but it is closely related with their ability
to generated oxygen-centered radicals.
The in vivo results obtained for the library of synthetic halo-
genated bacteriochlorins indicate that they are nontoxic even at
high drug doses (up to 100 mg/kg BW) and preferentially accumu-
late in organs such as the spleen, liver and tumor. It was estab-
lished that the maximum concentration of halogenated
bacteriochlorins accumulated in murine melanoma tumors is
observed after 24 h post-PS administration [180,181]. For the pho-
todynamic therapy in vivo, the tumors with a diameter of approx.
0.5 cm were selected [154]. After 24 h post-PS or i.v. injection of
photosensitizer, tumors were irradiated with laser light (650 or
750 nm) with a power ranged from 50 to 100 mW/cm2. It has been
shown that excitation of the sulfonated bacteriochlorin with laser
light from the near-infrared range results in significant inhibition
of tumor growth after photodynamic therapy in all tested experi-
mental groups of animals [154,155,178,180,242]. Moreover, after
photodynamic treatment with analogs sulfonated chlorin, the
complete curative effect can also be observed. Noteworthy is that
chlorin derivative was found to be more effective in vivo, despite
the much inferior photodynamic effect determined in vitro and less
favorable spectroscopic properties [181,183]. This effect was
explained by relatively higher redox potentials examined for this
chlorin derivative, and in consequence, its higher photostability
(the quantum yield of photobleaching for this compound was
lower by one order of magnitude when compared with bacteri-
ochlorin analog). The higher stability of chlorin derivative also
influences its pharmacokinetics and interactions in biological envi-
ronment after administration in vivo. This photosensitizer indicates
to be more biocompatible and shows improved pharmacokinetic
properties characterized by longer circulation time in the body
and thus, higher ability of accumulation in the tumor tissue
[158,181,184]. The photoactive drug designed for cellular tageting
should lead to high T/S and T/M ratios and be characterized by high
bioavailability. Both requirements are revealed for chlorin deriva-
tive; thus, it can be suggested that investigated chlorin derivative
as photosensitizer allows achieving acceptable profiles of tolerabil-Fig. 29. Comparison of the photodynamic effect (left) with the generation of hydroxyl
F2BMet) depending on the applied PS concentration with a NIR light dose of 0.16 J/cm2.ity, safety and high therapeutic efficacy in photodynamic therapy
of murine tumors [183]. Despite such therapeutic success, in fur-
ther studies, even more effective photosensitizers were sulfon-
amide derivatives [155,158]. In all PDT-treated mice with a
bacteriochlorin-based photosensitizer, complete tumor regression
was observed with no normal tissue damage in the immediate
vicinity of the tumor. The explanation of this therapeutic outcome
may be related to higher photostability of sulfonamide derivatives
and more favorable spectroscopic properties [54,142]. The lead
compound from this library is difluorinated sulfonamide bacteri-
ochlorin (F2BMet, redaporfin). The high phototherapeutic efficacy
of redaporfin was confirmed in various tumor models (e.g., CT26,
A549, LLC, B16F10) [54,155,156,180,184,192]. The dose-
escalation and toxicological studies demonstrated the low toxicity
of redaporfin and its CrEL-based formulation after application with
optimized PDT protocol (DLI = 15 min; drug dose = 1.5 mg/kg; light
dose = 74 J/cm2; laser power = 130 mW; margin Ø = 13 mm). For
instance, redaporfin-PDT of a CT26 tumor-bearing BALB/c mice
provided a significant long-term antitumor effect with a high cure
rate of 83% [154,242]. The mechanisms of photodynamic activity of
redaporfin were studied in detail and this photosensitizer reached
clinical trials in the treatment of head and neck cancers
(NCT02070432) [248,249]. Parallel to the clinical trials, there are
ongoing studies on the use of redaporfin for PDT treatment of mul-
tidrug resistanct (MDR) tumors [250] and in the combined therapy
with immune checkpoints inhibitors.
5.3. Vascular effects of redaporfin-based PDT
Based on the results of the comprehensive research described
above, redaporfin has been chosen for the evaluation of vascular
effect in PDT. Studies carried out on S91/I3 tumors growing in
DBA/2 mice indicated that treated tumors are characterized by
an extended hypoxic fraction (mean pO2 level in tumors with a vol-
ume of 50–100 mm3 reached value about 2 mm Hg). Cellular-
targeted PDT with F2BMet (DLI = 72 h) initially leads to distur-
bances in the structure and function of vessels, and then to the nor-
malization of vascularity (about nine days) in the PDT-treated area.
In contrast, therapy directed against tumor vasculature
(DLI = 15 min) destroyed the vascular structure in the tumor and
led to complete inhibition of their functionality for about 48 h after
irradiation. These effects consequently led to strong tumor hypoxia
(pO2 = 0 mm Hg) [251]. Results of following in vivo studies per-radicals (right) for four selected bacteriochlorin derivatives (ClBEt, Cl2BEt, FBMet,
Fig. 30. Effects of redaporfin-PDT on tumor oxygenation and blood flow in C57 mice bearing LLC tumors: (A) electronic absorption and fluorescence spectra of redaporfin; (B)
Kaplan–Meier survival plot determined for controls (untreated mice) and animals subjected to redaporfin-PDT; (C) representative examples of treated tumors and power
Doppler images of tumors registered before and after PDT; (D) Hypoxia evaluation using tumor oximetry (oxygen maps) and immunohistochemical staining with
pimonidazole performed for untreated and photodynamically-treated LLC tumors. Adapted from [192].
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ment of long-term antitumor response as a consequence of vascu-
lar occlusion and tumor starvation. In the case of C57 mice bearing
LLC tumors, the complete curative effect was observed in 67% of
animals followed for over a year after PDT treatment. This signifi-
cant effect can be mediated by, i.e., bacteriochlorin-based PS prop-
erties as well as real-time monitoring of oxygen distribution, its
intertissued concentration and controlled density of tumor vascu-
lature before and after treatment, Fig. 30 [192]. These data reveal
that in the case of LLC tumors, V-PDT results in more significant
therapeutic success than other PDT protocols with longer DLIs
(e.g., E-PDT or C-PDT).
5.4. The antitumor immune response after bacteriochlorin-based PDT
It is recognized that PDT can trigger rapid inflammatory
responses that are essential for the activation of antitumor immu-
nity and long-lasting protection against metastasis. The generation
of post-PDT antitumor response involves the participation of vari-
ous mechanisms based on the secretion of cytokines and mediators
associated with the inflammatory processes, increased level of
neutrophils in the blood combined with neutrophil recruitment
to the treated areas, and induction of acute-phase proteins and
activation of the complement system [252–255]. PDT-induced
inflammation is associated with the influx of the cells of theimmune system to the treated area, and these cells contribute to
the development of an immune response that recognizes cells that
survived the therapy [256,257].
The effect of V-PDT on the immune system was investigated
with Tookad Soluble as photosensitizer and the antitumor immune
response was indicated as the main factor responsible for the
observed overall therapeutic efficacy [258]. The long-term sys-
temic antitumor immunity involves both cellular (e.g., activation
of lymphocytes) and humoral pathways, including changes in the
antigens recognized by the serum immunoglobulins (IgG) and B
cells recruitment. The anticancer activity was defined as cross-
protective against different tumors (CT26 and 4T1 tumor-bearing
BALB/c mice), suggesting that V-PDT-mediated production of both
type tumor-derived antigens may be related to endothelial origin.
Thus, it can be suggested that locally applied V-PDT can be com-
bined with other antitumor strategies (e.g., immunotherapy) for
the enhancement of antitumor immunity in the treatment of both
local tumors as well as distant metastases [258].
Pd-Bacteriopheophorbide-mediated PDT (5 mg/kg, 650–800 nm
light dose of 360 J/cm2) against established C6 tumors (rat glioma)
growth in CD1 nude mice resulted in complete tumors regression.
Moreover, PDT decreased the kinetics of tumor growth and
reduced possible lung metastases which was not observed after
surgery [107]. V-PDT against renal cell carcinoma also potentiated
systemic antitumor immune response by PD-1/PD-L1 immune
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were treated with either V-PDT alone, with PD-1/PD-L1 antagonis-
tic antibodies alone, or with a combination of V-PDT and antibod-
ies. The results confirmed that only V-PDT in combination with
systemic PD-1/PD-L1 pathway inhibition, resulted in the regres-
sion of primary tumors, prevented growth of lung metastases,
and significantly increased prolonged survival. It also demon-
strates the crucial role of local immune modulation with PDT in
combination with PD-1/PD-L1 pathway inhibition for the genera-Fig. 31. Impact of redaporfin-V-PDT on long-term antitumor immune response generatio
and cured with V-PDT (PS dose of 0.75 mg/kg, DLI = 15 min, 50 J/cm2, 130 mW/cm2, m
metastasis determined by the number of developed lung metastasis as well as the weigtion of systemic antitumor response [230]. Elimination of primary
tumors and control of metastasis after PDT was also reported for
redaporfin. The antitumor immune memory of CT26 tumor-
bearing BALB/c mice cured with the V-PDT was compared with
the group cured by surgery, Fig. 31A. It was observed that all the
mice treated with surgery developed tumors in contrast to animals
rechallenged with CT26 cells in the contralateral thigh. Accord-
ingly, in this group, 67% of redaporfin-PDT treated mice remained
cured for more than three months. This immune memory effectn: survival analysis of BALB/c mice after rechallenge with CT26 cells of mice treated
argin 13 mm) or surgical tumor resection (A); the impact of V-PDT on distant lung
ht of the lungs (B). Adapted and modified from [242].
Fig. 32. The role of the lipophilicity of photosensitizer in selection of phototherapeutic protocol (V-PDT, E-PDT, C-PDT) and its impact on the biological response activation
with generation systemic antitumor immune response via local inflammatory reaction and cytokines expression [156].
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ulating the immune system via activation of T cell adaptive immu-
nity and long-lasting protection against metastases, Fig. 31B [242].
More recently, it was reported that the PDT regimes with
polarity-tunable bacteriochlorin lead to different biological
responses with the activation of distinct immunological compo-
nents, Fig. 32 [156]. Various degrees of local inflammation is
observed after different PDT regimes. The analysis of selected
cytokines present in the blood before and 24 h after the PDT
showed increased IL-6 concentration in plasma after PDT, as
expected from the observed inflammation. The enhanced concen-
tration of KC and MIP-2 chemokines after PDT suggests that tumor
response may involve an influx of neutrophils to the tumor. More-
over, the optimal protocols with sulfonamide bacteriochlorins (F2-
BMet-V-PDT and Cl2BHep-C-PDT) are characterized by increased
secretion of MIP-1, which is also involved in neutrophilic inflam-
mation. The optimal protocols also indicated the increased level
of TNFa activity and decreased VEGF expression, especially after
anti-vascular treatment. These findings offer the molecular basis
of how the changes in selected biomarkers after PDT contribute
to mounting an adaptive immune response capable of inducing
immunological memory and recognition of tumor cells that have
survived the local PDT treatment [156].5.5. Photodynamic efficacy enhancement by PS functionalization
The direction of the research consisting of the construction of
phototherapeutic systems dedicated to targeted therapies has also
contributed to the use of nanotechnology in the design of photo-
sensitizers with higher pharmacological activity and simultaneous
minimization of side effects (allergic reactions, long retention time
in the body). Additionally, the use of new formulations and selec-
tive systems for the supply of bacteriochlorins allows to increase
their (photo)stability, accumulation in cells, reduces the aggrega-
tion in the biological media, and eventually increases in vitro and
in vivo efficacy [259–262]. They also affect significantly the phar-
macokinetics and pharmacodynamic parameters ensuring pre-ferred tissue distribution in the body [263–266]. Moreover, they
influence not only the photophysical properties allowing the con-
trol of the electron and energy transfer processes but also the local-
ization of induced photodamages. The use of various
functionalization pathways enables determination of the relation-
ship between the structure and physicochemical properties as well
as biological activity of bacteriochlorins in the context of their
application in photomedicine [53,174,175].5.5.1. Polymeric micelles and nanoparticles
Several drug delivery nanosystems have been designed to target
many tetrapyrrolic-based photosensitizers towards cancer cells
and tumor microenvironment [265,267,268]. Considering the
hydrophobicity of bacteriochlorophyll derivatives, Gomes et al.
have evaluated the photophysical and photochemical behavior of
BChl a, when loaded into a drug delivery system (DDS) such as
poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles. Nanoparticles
of biodegradable poly(D, L-lactide-co-glycolide) loaded with BChl
a were successfully synthesized with high yield and satisfactory
incorporation efficiency using a solvent evaporation technique.
The authors described the method suitable for the encapsulation
of BChl a and enabling safe in vivo administration [269]. BChl a
has shown to be a promising alternative to the molecules currently
being used in PDT due to its spectroscopic properties, such as a NIR
absorption at 770 nm (in toluene) and 782 nm in an aqueous solu-
tion of nanoparticles, respectively. Moreover, the increased singlet
oxygen generation quantum yield (U=0.31) is related to the ROS
formation mainly via type II photoreactions.
The functionalization of redaporfin with Pluronic copolymers
increased the effectiveness of the therapeutic regimens [180].
The pharmacokinetic profile and photodynamic efficacy of
redaporfin-CrEL, redaporfin-F127, and redaporfin-P123 in animal
models (B16 melanoma-bearing C57BL/6J mice) were determined.
The results of the conducted research indicate the possibility of a
significant increase in the selectivity of the applied photosensitizer
and the possibility of obtaining a 100% long-term cure for animals
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col [180].
5.5.2. Lipoproteins
Lipoproteins represent the class of biocompatible, nonimmuno-
genic complexes containing the lipids and proteins, which are ideal
for efficient drug loading and delivery. Many lipoprotein-based
nanoparticles create the opportunities for enhanced therapeutic
and theranostic effect through mimicking the shape and structure
of endogenous lipoproteins. Due to the small size (>30 nm) of the
low- and high-density lipoproteins (LDL and HDL, respectively),
they can avoid the reticuloendothelial system (RES) and penetrate
the tumor tissue more deeply. In addition, they are characterized
by longer circulation time in the body. Moreover, lipoproteins are
useful in cancer treatment because many tumors (e.g., colon,
breast, prostate) indicate increased expression of LDL receptors.
Furthermore, LDLs may also be re-targeted to folate receptors that
are more specific to the selected type of human tumors [270,271].
Marotta and coworkers have developed the LDL-based delivery
system for lipophilic bacteriochlorophyll derivative – bacteriochlo-
rin e6 bisoleate (abbreviated as r-Bchl-BOA-LDL) for its used in
PDT. Bis-oleate or bis-stearate moieties have also been applied
for loading of hydrophilic dyes (like tricarbocyanines) and Gd-
chelating substituents into the phospholipid monolayer of LDL
[272]. The biological activity profile of r-Bchl-BOA-LDL was inves-
tigated in vivo on human hepatoblastoma G2 (HepG2) tumors.
When compared with untreated control mice, the kinetics of tumor
growth was significantly delayed after PDT with PS dose of 2 mmol/
kg and different light doses (125, 150 or 175 J/cm2). Moreover,
assessed phototoxicity against tumor as well as minimized healthy
tissue damages confirm that r-Bchl-BOA-LDL may be used as an
effective PDT agent [272].
5.5.3. Metal-based nanoparticles
Nanoparticles (NPs) and, more specifically, noble metal NPs are
widely-known agents for many biomedical applications, including
promising drug delivery systems and diagnostics tools. In general,
noble metal NPs (e.g., Au, Ag) indicate the high surface-to-volume
ratio and appropriate, tunable spectroscopic properties that may
be modulated to desired wavelengths. Such tuning is possible
due to their shapes (nanorods, nanoshells, etc.), size (up to
100 nm), composition (core/shell or alloys) and potential surface
modification and functionalization [273]. Pantiushenko and
coworkers have described the comprehensive characteristics of a
new type of materials containing bacteriochlorophyll isolated from
non-sulfur bacteria Rh. capsulatus. This derivative posseses the
disulfide moiety derived from lipoic acid. Such types of
bacteriopurpurinimides-based photosensitizers are characterized
by aurophilicity (a phenomenon referring to the aggregation of
gold complexes). Due to the possibility of the formation of S–Au
bonds, such properties allow obtaining the conjugates with gold
nanoparticles (NP-Au). The conjugation is related to the red-
shifted NIR absorption (at kmax = 824 nm) and fluorescence emis-
sion at kmax = 830 nm. The biological tests performed in vivo in rats
bearing M1 sarcoma indicated the favorable biodistribution of PS-
Au estimated by real-time dynamic fluorescence imaging. The
authors have reported that PS-Au conjugates exhibited a longer cir-
culation time in the blood than free bacteriochlorophyll a as well
as enhanced accumulation in tumor tissue that makes it a more
effective nanoformulated theranostic agent [274].
The other type of NPs are magnetic nanoparticles consist of a
metal/metallic oxide core, encapsulated in an inorganic or a poly-
meric coating shell. This shell renders the properties of the parti-
cles, such as their biocompatibility and stability, as well as may
act as a support for many biomolecules. Their magnetic properties
enables their application as MRI contrast agents, hyperthermiaagents, magnetic wand vectors controlled by magnetic field gradi-
ent towards a selected location similar to targeted drug delivery
systems [275]. The bacteriochlorin-loaded magnetic nanoparticles
dedicated to personalized MRI-guided PDT were recently
described. The bacteriochlorin derivative with a positive charge
and various-lengths linker between the amine group and macro-
cyclic ring was efficiently encapsulated in HSA coated metal NPs
via electrostatic and hydrophobic binding. After successful encap-
sulation, magnetic NPs-HSA-PEG nanoparticles provide long-term
stability as well as effectiveness in delivering PS to cancer cells in
both in vitro and in vivo systems. Moreover, this kind of conjugates
reveals that they can be applied in in vivo MRI imaging for efficient
drug delivery into the tumor milieu [276].
The same research group performed a primary screening of
bacteriochlorin-based photosensitizers containing aminoamide,
propyl, and peripheral carbohydrate substituents. The authors per-
formed the comprehensive spectroscopic characteristics of these
compounds, determined their stability as well as dark and photo-
toxicities against HepG2 cancer cells [277]. All studied photosensi-
tizers except the bacteriochlorin substituted with carbohydrate
moiety in the exocycle E were not cytotoxic in the dark and led
to the strong photodynamic effect. The highest photoactivity was
noticed for aminoamide-bearing photosensitizer, for which two
hours of incubation led to the IC50 in the range of 17–49 nM).
Based on all of the determined physicochemical and biological
properties for this group of agents, O-propyloxime-N-propoxybac
teriopurinimide methyl ester was ranked as the most promising
agent in the treatment of tumors [277]. These studies were further
continued by Plotnikova et al. in order to develop the formulation
for O-propyloxime-N-propoxy-bacteriopurpurinimide methyl
ester. The CrEL micellar emulsion was indicated as a promising for-
mulation of this photosensitizer and was of great interest for fur-
ther studies in the field of PDT [277].
5.5.4. Metal-organic frameworks (MOFs)
Nanovehicles designed for therapeutics have gained increasing
interest, as these systems allow to avoid many disadvantages of
traditional treatments. A new class of hybrid organic-inorganic
materials is represented by metal-organic frameworks (MOFs),
containing selected metal ions and organic bridging ligands. MOFs
may be promising nanoplatform for selective drug delivery, with
the opportunity of high drug loading, biocompatibility as well as
wide-spectrum functionality and applications [278]. The
hydrophobic character of many tetrapyrrolic derivatives may be
a reason not only for insufficient selectivity towards tumors but
also may cause aggregation and reduce the efficacy of PDT. How-
ever, this makes them very attractive examples of organic ligands
in the MOF structure [279]. The use of tetrapyrrole-based MOFs
designed for PDT application have been investigated. However, in
many cases, they are conjugated with other nanoparticles forming
dual-agents for synergistic strategy (including PDT-photothermal
therapy, PDT-radiotherapy). Recently, bacteriochlorin-based MOF
was prepared as a NIR-absorbing dual-mode photoagent for pho-
toacoustic imaging PAI-guided PDT [279]. This MOF contains the
5,15-di(p-benzoato)bacteriochlorin (H2DBBC) as blocks and central
clusters, including Hf6(m3-O)4(m3-OH)4 (abbreviated as DBBC-UiO).
This hybrid material was dedicated to the treatment of hypoxic
tumors due to the ability of ROS generation via both types of pho-
toreaction with singlet oxygen as well as oxygen-centered radicals
formation, Fig. 33. It was reported that the DBBC-UiO MOF could
generate superoxide anion within a severe hypoxic microenviron-
ment, and, that the part of the generated amount of O2 is con-
verted into hydroxyl radicals via SOD-induced catalytic process
upon irradiation with NIR light [279]. This effect suggests that
the photoactivity of DBBC-UiO may also be oxygen-independent
and effective against hypoxic tumors. In the following studies,
Fig. 33. The scheme of the synthetic procedure for metal-organic framework DBBC-UiO formation and its potential application for photoacoustic imaging and photodynamic
therapy. Adapted and modified from [279].
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and these data indicate that it could also be used as an agent for
diagnosis of cancer with deeper tissue penetration and increased
resolution [279].6. Application of (metallo)bacteriochlorins in photodiagnosis
(PD) and imaging
The growing interest in cancer detection focuses on the ability
for better visualization of selected probes that target diseased tis-
sues. Real-time imaging of designed fluorescent probes enables
the improvement of both basic and preclinical research. The pho-
tons from the near-infrared region are able to penetrate biological
tissues more efficiently than visible light [3]. However, at wave-
lengths k>950 nm, these effects are reduced due to increased
absorption of water and lipids. Thus, the phototherapeutic win-
dow used in PDT (630–850 nm) is not optimal for photodiagnosis,
considering the higher background signal from tissue autofluores-
cence as well as limited light penetration through tissue (1–
2 cm). Therefore, in photodiagnosis the optical window covers
the range from 700 nm to 900 nm [280]. In this region, the
endogenous pigments do not absorb and, consequently, do not
interfere with the NIR-fluorescent molecules [281–284]. More-
over, NIR photons indicate a lower ability to generate ROS due
to the lower energies in this part of spectra [3,6]. The spectro-
scopic properties of bacteriochlorin derivatives indicated the
strong absorption band between 700 and 800 nm is of particular
interest because it allows higher tissue penetration depth and
avoids the optical interferences with endogenous pigments. The
ability to distinguish multiple-color molecular markers during
fluorescence imaging is one of the most appropriate feature. Such
an effect can be achieved by using an appropriate probe or in
combination of selected labelling-agents. These fluorophores
should indicate significant Stokes shifts derived from well-
separated absorption and fluorescence emission bands. Moreover,
this property reduces the signal of the scattered excitation light,and consequently, to improve the quality and resolution of regis-
tered images [36,285].
Several NIR fluorophores, like cyanine dyes (Cy5, Cy7), indocya-
nine green (ICG), Alexa Fluor compounds as well as tetrapyrrole-
based fluorochromes have been extensively developed for biomed-
ical applications [38]. Despite the fact that some commercial
probes are based on these structures, several new classes of label-
ling agents, including bacteriochlorophyll- or bacteriochlorin
framework are still being developed. Besides the favorable charac-
teristics, some of the studied bacteriochlorins demonstrated limi-
tations for their successful application. The major limitations are
due the reduced stability of bacteriochlorins. As previously
described, many efforts have been taken to modulate the stability
of BChls, including peripheral modification of the macrocycle, the
introduction of the serine or halogen atoms as substituents, inser-
tion of central metal ion, or encapsulation in selected drug delivery
systems. For instance, Ptaszek and coworkers have described sev-
eral promising dyads with potential use as optical imaging probes
[37,38]. The chlorin-bacteriochlorin, as well as BODIPY-
bacteriochlorin complexes are able to take part in the efficient
energy transfer, and thus, are considered as promising fluorescence
probes. In such a chlorin-bacteriochlorin system, chlorin acts as an
energy donor and bacteriochlorin plays an energy acceptor role.
Excitation of the chlorin leads to stronger fluorescence emission
derived from bacteriochlorin [37,38]. This complex exhibits several
desirable properties, including strong absorption and fluorescence,
narrow bands with FWHM <20 nm and large Stokes shift over
85 nm. Moreover, these chlorin-bacteriochlorin dyads are charac-
terized by relatively long-lived excited singlet state ca. ~5 ns
[38]. Additionally, the fluorescence properties can be tuned by a
structural modification and changes in the peripheral substitution
patterns. In other studies, the BODIPY-bacteriochlorin complex
was synthesized and characterized, Fig. 34 [286].
In this type of bioconjugates, the BODIPY molecule, contrary to
chlorins, possesses increased hydrophilicity and high molar
absorption coefficient in the green range of spectra. However,
due to the bulky aromatic structures and overall hydrophobicity,
Fig. 34. Electronic absorption and fluorescence spectra as well as the chemical
structure of boron-dipyrromethene (BODIPY)-bacteriochlorin energy-transfer
dyads with activatable near-infrared fluorescence. Adapted and modified from
[286].
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alter their pharmacokinetics in vivo [287]. To achieve enhanced
selectivity and active targeting of fluorescent probes, many efforts
were undertaken, including the conjugation with antibodies.
Unfortunately, probe-antibody complexes (e.g., panitumumab-
bacteriochlorin conjugates) were characterized by increased
hydrophobicity and were prone to aggregation [287].
Moreover, the synthesis and characterization of the other bacte-
riochlorin derivatives (named as NMP4 and NMP5) were reportedFig. 35. Chemical structures of the bacteriochlorin derivatives named NMP4-NHS ester a
fluorescence imaging of ovarian cancer (SHIN3) after i.p. administration with hGSA-NMin terms of their use as targeted photodiagnostic agents [285].
These compounds, after excitation with a green light indicate the
fluorescence emission in the NIR (k ~ 739 nm for NMP4 and k
~ 770 nm for NMP5, respectively) [285]. In the subsequent studies,
these bacteriochlorins were conjugated to galactosyl-human
serum albumin (hGSA) or glucosyl-human serum albumin (glu-
HSA), which are the molecules with affinity to H-type lectins. Thus,
these complexes were enabled to target, i.e., b-D-galactose recep-
tors, which are expressed on ovarian cancer, Fig. 35.
The in vivo multicolor imaging was performed in mice bearing
ovarian cancer metastases. The excitation of bacteriochlorin with
green light results in various NIR fluorescence emissions that
may be detected apparently from each fluorophore. The selectivity
towards targeted receptors was achieved and also enhanced due to
the unique fluorescence properties. The fluorescence emission of
bacteriochlorin conjugated to hGSA are normally quenched [285].
Nevertheless, after binding to H-type lectin on the surface of can-
cer cells, the fluorescence signal was observed showing the tumor
localization. The described activity of these compounds was
reported only in the case of peritoneal metastases. Based on single
excitation, two-color NIR fluorescence imaging with
bacteriochlorin-based photoactivatable complexes was developed
and reveal that they are worth further investigation [285].
In other studies, Liu et al. have described the bacteriochloro-
phyll derivative that might be used in multimodal theranostics
[288]. The molecular design of this probe consists of bacteri-
ochlorophyll molecule conjugated with a targeting peptide that
enables modifying the pharmacokinetic profile as well as recogni-
tion of folate receptors on the cancer cells surface. Moreover, this
probe indicated significant, red-shifted fluorescence emissionnd the NMP5-NHS ester (A), the absorption and emission spectra of NMP5-NHS, and
P4 or hGSA-NMP5. Adapted from [285].
Fig. 36. Lanthanide complexes of porpholactone derivatives as efficient photodiagnostic tool: (a) scheme for TTA-UC via conventional triplet sensitization routes; (b)
H2DCFDA fluorescence images of HeLa cells after treatment with Gd-derivatives; (c) the structure of the Yb3+ porpholactone complex and its sensing for glucose oxidase; (d)
b-fluorinated Yb3+ complexes applied in in vivo imaging (fluorescence-guided sentinel lymph node surgery). Adapted from [290].
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probe and the possibility of targeting the folate receptor-
expressing cancer cells, its accumulation of tumor tissue was
investigated in vivo in KB- and HT1080- tumor-bearing nude mice.
In these animal models, KB tumors were characterized by high
folate receptor expression and HT1080 with low expression,
respectively. Besides the fluorescence imaging, performed studies
revealed high in vitro phototoxicity as well as significant photoac-
tivity in vivo resulted in complete tumors regression. Thus, these
findings provide that the modified BChl derivative can be a promis-
ing dual-mode agent for NIR fluorescence imaging and PDT pur-
poses [288].
In the context of photodynamic treatment, the new frontier is
related to selective and controlled light delivery with possible visu-
alization of the administered photosensitizer. Even though the
insertion of the optic-fiber into the body and selected internal
organs is usually supported and controlled by standard techniques
including ultrasonography, optical, or X-ray imaging, the complete
and real-time monitoring of the delivered light and the direct
impact on tissue response during PDT is currently unavailable
[289]. This limitation may be dangerous in the case of tumors
localized closely to vital organs, major blood vessels or nerves,
because then the light must be spared to avoid the damages or
medical complications [289]. In such cases, the precise light deliv-
ery during PDT is desirable. For instance, Scherz with collaborators
have evaluated the opportunity of the use of blood oxygenation
level-dependent (BOLD) contrast MRI for real-time and dynamic
monitoring of PDT procedure. They developed this technique using
Tookad-PDT against prostate cancer and indicated that during pho-
todynamic treatment, the significant attenuation (ca. 25–40%) of
the magnetic resonance signal might be observed only in tumor
area subjected to the irradiation [257]. All of the described results
reveal that photosensitized BOLD-contrast MRI may be appliedintraoperatively as interactive guidance for monitoring antivascu-
lar cancer therapy, cardiology, PDT for age-related macular degen-
eration (AMD) as well as other biomedical purposes [289].
Lanthanide complexes are characterized by strong lumines-
cence in the NIR, with an extremely narrow band, making them
ideally suited for use in developing new multifunctional lumines-
cent materials. Unfortunately, these complexes exhibit low molar
absorption coefficients due to forbidden f–f transitions. This prob-
lem may be omitted by using tetrapyrrolic ligands, characterized
by strong absorption and efficient energy transfer from its triplet
state, which lay higher than excited state of the lanthanides. The
complexation of lanthanide metal ion by tetrapyrrolic ligand
enhances the NIR emission and extends the phosphorescence life-
time by narrowing the energy gap between the triplet state of
ligand and the excited state of the metal ion (triplet-triplet annihi-
lation upconversion mechanism, TTA-UC, Fig. 36A). The properties
of free-base porpholactone ligands and lanthanide(III) metal com-
plexes (Ln = Lu3+, Gd3+, Yb3+) and their biological activity studies
including cellular-uptake as well as photocytotoxicity was per-
formed by Zhang and co-workers [169,170,290]. The comparison
of free-base tetrapentafluorophenylporphyrin (F20TPP), porpholac-
tone (F20TPPL), cis/trans porphodilactone and their Gd3+ complexes
show, that especially in case of trans-isomers the phosphorescence
is red-shifted with decreased lifetimes and phosphorescence quan-
tum yields [290]. Moreover, the incorporation of the heavy atom
(Gd3+) enhanced photocytotoxicity of these compounds upon red
light irradiation that makes them most promising for PDT,
Fig. 36B. Furthermore, the presence of Gd3+ in porpholactone struc-
ture allows the rational design of dual-mode photosensitizers due
to both therapeutic and diagnostic agents within the same molec-
ular scaffold [290]. Similarly to free-base, the cis/trans isomers of
porphodilactones have significant differences in quantum yields
of the triplet state of Yb3+ complexes. Due to this fact, Zhang
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thanide poprholactone-based luminescent sensor. In this probe,
the NIR emission of Yb3+ is specifically switched-on by glucose oxi-
dase and then switched-off in the presence of glucose (Fig. 36C).
This phenomenon indicates that porphodilactone-based ligands
enhance the quantum yield of Ln luminescence and may be used
in several biomedical applications, Fig. 36 [290]. The upconversion
fluorescence imaging is a promising method due to their biological
and technical specification, including excellent photostability, nar-
row emissions bands, absence of photodamage to living organisms,
absence or very low auto-fluorescence, high sensitivity, and high
penetration into biological tissues. Upconversion is a non-linear
optical process, which involves the conversion of two or more
low energy photons (from the NIR) and emits radiation with higher
energy [291]. Thus, its potential is commonly used not only in
diagnostics but also in PDT [292]. The functionalization of these
fluorescent probes may be combined with other imaging methods
such as magnetic resonance imaging, positron emission tomogra-
phy and computed tomography. Porphodilactone complexes with
Lu3+ are suitable for upconversion based on triplet-triplet annihila-
tion [290]. Moreover, they display much longer phosphorescence
decay lifetimes (ls scale) than the Pt2+, Pd2+ complexes (ms), and
thus can be applied in upconversion-based imaging [169].
Other examples of upconversion probes are nanoparticles and
nanocrystals doped with metal ions, especially by f-block metals
[291,292]. Moreover, the immobilization of nanoparticles with lan-
thanide porphyrinoids allows to overcome the major limitation of
traditional porphyrin-based photosensitizers for practical applica-
tion of PDT such as weak absorption in the red region and poor bio-
compatibility [292]. Similarly to bacteriochlorins, the
porpholactones and their metal complexes possess higher cellular
uptake than porphyrin, which is crucial for their in vivo evaluation
[169]. Furthermore, porpholactones are characterized by a high
binding affinity to low-density lipoproteins (LDL). The cytotoxicity
tests also reveal that b-lactonization of porphyrin leads to a more
prominent photodynamic effect against HeLa cells with
photodynamically-induced cell death via apoptosis [169].7. Application of bacteriochlorins in photodynamic inactivation
of microorganisms (PDI)
The bacteria-related diseases are becoming a serious worldwide
health problem due to the increased multi-drug resistance [293].
Although many antibiotics are effective against Gram-positive bac-
teria, the clinical manifestation of multi-resistant bacterial infec-Fig. 37. Scheme of photodynamic inactivation of microotions, especially caused by Gram-negative bacteria, is still
unsatisfactory. Moreover, microorganisms are capable of develop-
ing complex mechanisms of defense against the damages and
antimicrobial drugs by, for instance, creating their matrix named
biofilm as well as several virulence factors. Thus, the development
of new antibacterial strategies is urgently needed [294–297].
Among them, the photodynamic inactivation of microorganisms
(PDI) represents one of the most promising method that involves
the excitation of a photosensitizer to generate ROS. Due to the lack
of resistance to singlet oxygen, this highly reactive molecule may
initiate further oxidative reactions in the nearest environment,
such as nucleic acids, lipids, proteins, or enzymes [59,298]. There-
fore, PDI is based on the concept that a photosensitizer can accu-
mulate in the cytoplasmic membrane, which is the critical target
for damages after irradiation [298], Fig. 37 [299–301].
Many classes of photosensitizers were developed for efficient
PDI of bacteria, viruses and fungi [157,294,295,298,302–308]. It
appears that the most appropriate PDI photosensitizers are
positively-charged, water-soluble and photostable compounds
[309]. Moreover, affinity to bacterial cell wall is a crucial factor
which influences PDI efficacy. The differences in morphology
between the Gram-negative and Gram-positive bacteria are
responsible for PS interaction with the bacterial cell walls. The
presence of lipopolysaccharide (LPS) in the outer membrane of
Gram-negative bacteria provides an additional barrier to many
molecules in the external environment. It contributes to the
observed drug-resistance of these organisms. In contrast, Gram-
positive bacteria contain a single peptidoglycan layer with specific
proteins on the cell surface. The PDI effectiveness against fungal
yeast is limited by low diffusion of the drug into the fungal cyto-
plasm because of their cell walls, which also contain b-glucan.
Thus, PS with positively charged groups or the addition of sub-
stances able to increase the permeability of the outer membrane
outstanding enhance the efficacy of Gram-positive bacteria
inactivation.
As it has been claimed earlier, the most promising photosensi-
tizers for anticancer PDT are chlorins and bacteriochlorins. Por-
phyrins, however, can still be considered as efficient agents for
antimicrobial approach. Anyway, bacteriochlorins still seem to be
more promising for the treatment of biofilm, localized infections
and deeper wounds, due to the sufficient NIR light penetration
through tissues [310]. Besides the appropriate spectroscopic prop-
erties, a photoactive agent should have a high affinity to the bacte-
rial cell wall and allows penetration into bacterial cells [238]. The
examples of three mono-substituted cationic bacteriochlorins with
quaternary ammonium substitution (named BC37, BC38, BC39,rganisms (PDI) and its basic mechanims of action.
Fig. 38. Chemical structures of positively-charged bacteriochlorin derivatives designed for PDI application.
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tizers [311].
High effectiveness at nanomolar concentrations and low light
dose (10 J/cm2) against Gram-positive bacteria was reported for
bacteriochlorins presented in Fig. 38, with a different number of
positively-charged groups. The bacteriochlorin bearing two catio-
nic moieties indicates the highest activity against the resistant bac-
teria (at micromolar concentrations), whereas the hydrophobic one
was more effective against the fungi [311]. According to these
studies, it can be concluded that Gram-positive bacteria are more
susceptible to PDI by neutral photosensitizers or those with a mod-
erate number of positive charges with relatively low hydrophobic-
ity [311]. In contrast, effective photoinactivation of Gram-negative
bacteria requires more hydrophobic photosensitizers with many
positive charges in the structure [303]. In turn, fungal cells should
be treated with photosensitizers that have little or no positive
charge with relatively higher hydrophobicity [311].
It should also be highlighted that efficient photodynamic inac-
tivation of a broad-spectrum of pathogens can be achieved by a
protocol involving short photosensitizer-cell incubation time (up
to 2 h) and relatively low light dose (i.e., 10 J/cm2). Thus, in the fol-
lowing studies, the authors also showed that a short incubation
time (up to 30 min) might also result in increased selectivity for
microbial cells over human cells (HeLa cancer cell line) [311].Fig. 39. Examples of disubstituted positively-charged bacteriochThe possibility to use shorter incubation times in PDI than for typ-
ical photodynamic effect against cancer or eukaryotic cells is a con-
sequence of the fast-electrostatic interaction occurring between
cationic functional groups in PS structure and the negatively
charged teichuronic and lipoteichoic acids located in the outer wall
of bacterial and fungal cells [303].
In other studies, Hamblin with coworkers tested the next set of
bacteriochlorins containing a various number of cationic charges
against the different species of microorganisms, Fig. 39 [238]. It
was reported that all four derivatives indicate the PDI activity
against Gram-positive S. aureus. The most significant antibacterial
effect was achieved for the bis-quaternized derivative (5 logs
reduction after PDI with 100 nM PS). However, other bacteriochlo-
rins (basic, tetrakis- as well as hexakis-quaternized) showed simi-
lar but relatively lower than the best one, activity in bacteria
inactivation procedure (up to 5 logs of killing after PDI with
1 mM PS) [238]. The observed effect may be explained by the state-
ment, that there is an optimum number of cationic charges in the
photosensitizer structure, which is responsible for: (i) PS binding
to anionic phosphate groups present on the bacteria cell wall and
(ii) efficient penetration into the bacterial cell wall, where ROS
are produced upon irradiation leading to photodamages. The lower
than the optimal number of positive charges (for instance, neutral
bacteriochlorin derivative with two basic amino groups) dimin-lorins designed for photodynamic inactivation of bacteria.
B. Pucelik et al. / Coordination Chemistry Reviews 416 (2020) 213340 37ishes the sufficient binding. In contrast, the respective higher num-
ber of cationized groups like in bacteriochlorin containing 4–6 pos-
itive charges) result in too strong binding, which reduced the PS
penetration into the cell wall [238]. A similar finding has also been
reported for PDI with chlorin e6 conjugates with different-sized
poly-L-lysine [312,313] or polyethylenimine [313] chains as well
as porphyrin derivative [157,309,314]. Maisch et al. have con-
firmed that porphyrin-based photosensitizer with two cationic
groups indicated higher activity against S. aureus than an analog
molecule with four positively-charged substituents [314].
The observed results for cationic bacteriochlorins were also
supported by the photophysical studies and DFT calculation under-
taken in the following studies [238]. The theoretical analysis
revealed that the excited triplet state quantum yield, which is
the precursor of ROS, for the four bacteriochlorins is similar and
reached ca. 0.48–0.53 [238]. Moreover, any correlation between
the redox properties of photosensitizers was observed [238]. The
only noticeable trend is that mono-substituted bacteriochlorins
are more effective than di-substituted derivatives, which may sug-
gest that their photoactivity is associated with an increased prob-
ability of the electron transfer processes [238]. Thus, it can be
suggested that overall PDI activity observed among the set of bac-
teriochlorins must be related to both cellular binding and accumu-
lation rather than photochemical features. All of these data present
the basic information about the structure-activity relationship for
analyzed cationic bacteriochlorins and indicate the major factors
that influence their photodynamic activity [238].
Other authors also investigated the bacteriochlorin-based PDI-
photosensitizers. For instance, Meerovich et al. have also studied
the effect of cationic charges in the photosensitizer structure. It
appeared that the investigated tetracationic photosensitizers,
based on synthetic bacteriochlorins with reduced molecular size
and molecular weight, were highly efficient in photodynamic inac-
tivation of Gram-positive bacteria (S. aureus) and Gram-negative
bacteria (P. aeruginosa) and against their biofilms [315]. The
E. coli photoinactivation profile by cationic isobacteriochlorin
described by Faustino et al. also proved that by using adequate
PS, the PDI could be used in clinical applications. The results
obtained for the series of modified isobacteriochlorins confirm that
the trend of inactivation efficiency proceeds with the increasing
number of cationic groups in the PS structure. The synergistic
effect of red-shifted absorption and a positive charges in investi-
gated isobacteriochlorin led to a 6 logs reduction and indicated
that cationic isobacteriochlorins seem to be a promising agents
for photodynamic inactivation of Gram-negative bacteria.
The future outlook of the treatment of resistant pathogens is the
design and development of hybrid materials with multiple mecha-
nisms of action. For these reasons, nanotechnology-based strate-
gies in combination with PDI are more frequently explored
[295,304,305]. Properly designed hybrid nanosystems may
increase the affinity to microorganisms, enhanced ROS generation
as well as are able to overcome the multidrug resistance mecha-
nisms. The last one seems to be most important, due to the fact
that the present time is named as the ‘‘end of the antibiotic era”
[294]. This motivated a search for alternative antimicrobial strate-
gies, including PDI to overcome multidrug-resistance mechanisms
[294,302].8. Other applications of bacteriochlorins beyond the medicine
8.1. Application of (metallo)bacteriochlorins conjugates as a light-
harvesting antennas
The primary function of metallobacteriochlorins is to partici-
pate in the photosynthesis reactions consisting of, among others,the NIR photons absorption that leads to charge separation and
efficient transformation of solar energy into chemical energy in
the forms of sugars that later serve as fuel for leaving organisms.
Therefore, an increasing number of studies are being conducted
on the use of similar compounds as the potential light-harvesting
antenna (LHA) models. LHA that captures light energy and then
funnels excitation energy to the reaction center is very important
for natural photosynthesis. Among the reported natural or artificial
LHAs, porphyrins or their derivatives have been widely used as
donors or acceptors. However, the absorption spectra of por-
phyrins cover only a limited portion of the visible region, which
is a big barrier to light harvesting. The design of the bioinspired
light-harvesting devices using well organized supramolecular
arrays must be considered as one of the most promising system.
The requirements for ideal supramolecular assemblies are i.e.,
strong absorption, efficient solar energy storage and easily trans-
ferred without energy loss [316]. Metal-coordinated chromophores
assemblies are widely studied for antenna systems due to their
large molar absorption coefficients. In addition, metal ion coordi-
nation ensures a strong impact through ion interaction as well as
through the formation of a hydrogen bond [316]. The construction
is based on metallotetrapyrolles linked with free-base molecule by
linker with different hindrances and in different positions, which
provide changes in the HOMO-LUMO gap. Excellent energy trans-
fer and weak electronic coupling may be obtained by using such
a linker because the distance between linked chromophores as
well as a hindrance is crucial to ensure efficient excitation and
energy transfer.
In the systems containing Mg2+ or Zn2+ complexes as energy
donors and free-base acceptor, the energy transfer process is char-
acterized by short lifetime (s~25–115 ps) and high quantum yield
(U~95%) [317]. Another class of extensively studied artificial
antennas is encompassed synthetic tetrapyrroles, likely zinc
bacteriochlorin-bacteriochlorin (ZnBC-BC) complexes. Shoji,
Nomura, and Tamiaki have investigated covalently linked hetero-
dimers of porphyrin, chlorin, or bacteriochlorin with or without
zinc ion [124]. They have also compared the axial ligation of Zn2+
in porphyrins, chlorins and bacteriochlorins, concluding that the
more flexible and less p-conjugated bacteriochlorins bind axial
pyridine stronger than the corresponding chlorins or porphyrins.
They have reported several Zn2+ bacteriochlorins that, upon self-
aggregation, exhibit significant red-shifts in their absorption spec-
tra [318–320]. Based on naturally-occurring photosynthetic sys-
tems with a large number of excitonically coupled tetrapyrrolic
arrays or strongly conjugated by a linker (double and triple C–C
bonds) with faced model assembly were investigated [321]
Fig. 40 [117,122,322].
Ptaszek with co-authors have found out that the dimer of chlo-
rin (cis-2C), bacteriochlorin-chlorin (cis-2BC), and zinc-
bacteriochlorin-chlorin (cis-2ZnC) linked via enediyne bond exhib-
ited thermally stable isomers. The slipped co-facial arrangement of
the macrocycles, in which the structure may be stabilized through
space- and bond-interactions were studied [40]. Nevertheless, the
computational of the trans arrangement along linkage double bond
has no splitting. NMR spectra and DFT calculations predict the
antiparallel arrangement of macrocycles. In addition, theoretical
calculation confirms that the anti-parallel configuration of chro-
mophores provides the lowest energy for cis configuration of the
linking bridge. The introduction of Zn2+ into the system indicates
strong excitonic coupling in contrast to the identical free-base
supramolecular arrangement. The excited state of cis-2ZnC tends
to decay with reduced fluorescence. Additionally, the dimers of
the tetrapyrrolic core possess lower fluorescence quantum yield
(UF) compared to their monomers. This study shows that the
geometry and spectral properties of the investigated dyad are sim-
ilar to those observed in particular pairs involved in photosynthetic
Fig. 40. Example of dyads composed of two identical bacteriochlorin derivatives with different linker (top panel); and cis isomers structures calculated with DFT level of
theory approach (bottom panel). Adapted and modified from [321].
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of energy and electron transfer for modeling the photosynthetic
reaction pathway. In addition, the chromophores coupled with
enediine connector, able to subsequent photoisomerization to
trans-cis conjugates, seems to be useful elements for designing
the energy conversion systems and photonic materials with new
optical properties.
In the co-assembly model containing an aggregative zinc 31-
hydroxy-131-oxo-chlorin and free-base bacteriochlorin with
appropriate energy level, the covalently linked BChl heterodimer
was arranged in chlorosomal chlorin J-aggregates. In particular,
co-assemblies of porphyrin J-aggregates with heterodimers were
first developed, and the J-aggregates with zinc-chlorin with bacte-
riochlorin (ZnC-B) or zinc-porphyrin with bacteriochlorin (ZnP-B)
exhibited relatively higher intense emission than the free-base
bacteriochlorin conjugated with chlorin. The Zn2+ complexes pos-
sess a particularly narrow HOMO-LUMO gap. Thus, the intramolec-
ular photoinduced electron transfer processes to the nearest
molecule can easily occur. Zinc-bacteriochlorin linked by the
alkyne linker group with the sterically unhindered alkyne linker
(strong interactions) attached in the different sites is characterized
by a strongly reduced in the HOMO-LUMO gaps, and low
tetrapyrrolic-linker rotational barriers, Fig. 41 [123,323].
In contrast, bulky aryl linkers have limited interaction between
linked macrocycle resulting in increased HOMO-LUMO gap energy
and higher ZnBC-linker rotational barriers. The design of
supramolecular conjugates based on linker interaction is impor-
tant for development of efficient light-harvesting arrays [324].
Computational studies of these systems are very feasible and can
be helpful for further prediction of their application as a compo-
nents of the antenna system. Okuno and Mashiko have proposed
the mechanism of the interaction with different linkers and chro-
mophores in porphyrin arrays. The comparison of excitationenergy with rotational energy barrier for Zn-porphyrin shows
strong dependence, in contrast to the free-base analog, in which
the HOMO-LUMO energy gap is independent of p conjugation
[324].
8.2. Application of bacteriochlorins as chemical sensors
It is commonly recognized that optical sensors relying on fluo-
rescence detection indicate higher sensitivity than absorption-
based ones. For fluorescent optical sensors with optimized perfor-
mance and sensitivity, the use of a single-excitation and dual-
emission fluorophore allows for ratiometric signal processing. It
is essential to overcome some disadvantages (photobleaching,
indicator leaching, light source intensity fluctuations, etc.) of single
wavelength fluorescence intensity approaches. Suzuki, Tamiaki
et al. have described the use of bacteriochlorin derivative as a flu-
orescent ratiometric optical, chemical sensor (optode) for alcohol
detection [325]. In previous studies, the same authors reported
the synthesis of a trifluoroacetylchlorin as the first example of a
fluorescent probe for alcohols and amines using a chlorophyll
derivative as the central dye unit.
Due to the fact that optical sensors with spectral sensitivity in
the long-wavelength range are less prone to optical interference
(light absorption, autofluorescence), the authors appllied a lipophi-
lic derivative of 8-oxo-bacteriochlorin incorporated into a plasti-
cized poly(vinyl chloride) membrane. With this fluorophore,
sensitive and reversible ratiometric ethanol sensing in the NIR
range with reversible signal changes was achieved. Immobilization
of the fluorophore into a plastic membrane of the poly(vinyl chlo-
ride) dramatically change both, their absorption and emission
properties. The blue-shifted of fluorescence from 750 nm to
701 nm in the presence of ethanol may be used as an ethanol sens-
ing probe for beverage and industrial analyses [325].
Fig. 41. Spatial-arrangement of Zn-bacteriochlorin oligomer with linker in meso and b positions and their different electronic interactions [40].
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conversion
Metal complexes with tetrapyrrolic ligands, due to appropriate
excitation energy and high molar absorption coefficients in Vis/
NIR, are particularly interesting in terms of their possible applica-
tion in dye-sensitized solar cells (DSSC). The functioning of DSSCs
depends on the efficiency of the electron injection from a photoex-
cited sensitizer molecule to the conduction band of the semicon-
ductor, yielding mobile electrons and the oxidized dye. The
electron injection and recombination of separated charges at the
sensitizer-semiconductor interface are the crucial processes influ-
encing the efficiency of solar energy conversion [326,327]. Metal-
lotetrapyrroles, mainly with coordinated Zn2+, were successfully
used to sensitize TiO2 in DSSC [328]. Due to the strong absorption
within the green (ca. 500–550 nm) and NIR regions of spectra, the
bacteriochlorin derivatives are indicated as versatile molecules for
the construction of photovoltaic devices. So far, the most popular
DSSCs are these containing ruthenium complexes adsorbed at the
surface of nanocrystalline TiO2 to collect photons up to 650 nm.
However, their main limitation is the energy conversion efficiency
of 11%. Extending the absorption to 800 nm could increase the
maximum global solar radiation from 24% to 40%.
Organic solar cells are a prospective alternative for classical
solar energy conversion into electrical energy due to the effective
heterojunction of electrons in the active layer [329,330]. Among
the several types of polymers or small molecules based on
donor-acceptor, the conjugates with bacteriochlorin as a core with
two electron-withdrawing terminal units linked by two p-linkers,are characterized by remarkable photovoltaic productivity. How-
ever, power conversion efficiency (PCE) of the OSCs depends on
the strong absorption of the solar spectrum region and efficient
electron transfer by the active layer. In this context, Ponsot and col-
leagues have designed a molecule based on the electro-donor cen-
tral core of bacteriochlorin linked with two different electron-
acceptors groups via p linker bridges for heterofunctional organic
solar cells [330]. The use of small-molecule ligand as a comple-
mentary donor enables to increase of the efficacy of this binary sys-
tem up to 9.88%, which is probably related to a deeper HOMO
ligand energy level. In addition, the respective LUMO offset reaches
only ~0.30 eV, which is very similar to the threshold value neces-
sary for exciton dissociation and charge transfer in mass group
substitution causes heterojunction to the active layer with mini-
mal energy loss [330]. The authors indicated that the bacteriochlo-
rin with a more extended p-system exhibits a narrow HOMO-
LUMO energy gap, which is desirable properties for light-
harvesting in the NIR region of the solar spectrum [330].9. Summary and conclusions
Near-infrared (NIR) part of the electromagnetic radiation,
despite its advantages, has been relatively poorly used in medicine,
optoelectronics and photocatalysis due to the lack of thermally and
photochemically stable chromophores, that strongly absorb elec-
tromagnetic radiation of this range. Bacteriochlorins are an excep-
tional example of NIR-absorbing compounds. They have been
chosen by nature to conduct photosynthesis without the produc-
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selection is that these molecules efficiently absorb photons in the
range of 700–900 nm and have appropriate redox properties. The
best-known example of bacteriochlorin is bacteriochlorophyll a, a
natural pigment structurally similar to chlorophyll a, but contain-
ing two reduced pyrrole rings. This is the main reason why its nat-
urally occurring derivatives are characterized by reduced stability
and high cost of production. Therefore, in recent years there has
been an increased interest in obtaining rationally designed syn-
thetic bacteriochlorins, with more favorable photochemical prop-
erties and increased stability. The absorption spectra of
bacteriochlorins reveal an extraordinary high absorption in the
infrared (e ~ 100,000 M1cm1), a very high absorption in the near
UV, and relatively low absorption in the green part of the visible
light. The stability of synthetic bacteriochlorins is assigned to the
presence of desired metals ions, electron-withdrawing groups
(e.g., cyano, geminal dimethyl and halogen substituents) and steric
protection. The presence of such substituents in the bacteriochlo-
rin structure results in a marked increase in oxidation potentials
and thus, in a lower tendency of these compounds to photodegra-
dation. The proper control of oxidation potentials is also important
for the determination of ROS generation mechanisms, and more
precisely, for the engineering of photoinduced electron transfer
and energy transfer processes.
The possibility of introducing various functional groups and
metal ions into the bacteriochlorin core for fine-tuning of optical
properties and polarity and the increased possibility to obtain large
quantities of substantially pure metallobacteriochorins led to a
wide range of practical applications. They are useful antennae sys-
tems for light-harvesting in the near-infrared (NIR) and are consid-
ered as effective agents in the photodynamic therapy (PDT) of
cancer, photodynamic inactivation of microorganisms (PDI),
in vivo oxygen imaging, fluorescent labeling of biomolecules, pho-
todiagnosis (PD), solar energy conversion, optical sensing, and pho-
tocatalysis. The recent results from various scientific groups,
including our, have shown that bacteriochlorins are promising
compounds for PDT because they can use NIR radiation that deeply
penetrates through the tissues and convert it very effectively to
highly reactive oxygen species such as singlet oxygen, superoxide
ion, hydrogen peroxide and hydroxyl radicals. In vitro studies with
several families of (metallo)bacteriochlorins generally revealed
their low cytotoxicity in the dark and high phototoxicity to various
cancer cells. In a few independent studies, it was demonstrated
that the photodynamic effect does not depend on the quantum
yields of singlet oxygen formation, but it is strictly correlated with
the production of oxygen-centered radicals. Bacteriochlorins that
generate free radicals more efficiently lead to a more effective pho-
todynamic effect than photosensitizers generating only singlet
oxygen. The experiments performed on different animal models
showed favorable pharmacokinetics, biodistribution and photody-
namic efficacy. It was also demonstrated that the functionalization
of bacteriochlorins may increase the effectiveness of the applied
therapeutic protocols with polymeric micelles, lipoproteins,
nanoparticles and metal-organic frameworks.
The best example of a bacteriochlorin containing metal ion, that
has been successful in clinical trials, is Tookad Soluble (padeli-
porfin). After passing stage III and undergoing phase IV clinical tri-
als, it is finally approved in the European Union and in Mexico for
the treatment of low-risk early prostate cancer. Another
bacteriochlorin-based photosensitizer discussed in this work,
which is currently in Phase I/II of clinical trials, is redaporfin. Reda-
porfin is a photosensitizer from the family of halogenated bacteri-
ochlorins that absorbs NIR photons efficiently and convert them
into cytotoxic ROS. Its efficacy in the treatment of various types
of tumors, including lung, colon, prostate, breast and melanoma
has already been confirmed in preclinical tests. The promisingresults of Phase I/II clinical trials for the treatment of advanced
head and neck cancer clearly reinforce the beneficial results of
non-clinical studies. PDT with redaporfin as photosensitizer offers
a number of advantages over existing anticancer regimes, such as
improved efficacy, good tolerability, ease-of-use, and low-cost effi-
ciency. Some of (metallo)bacteriochlorin described herein are also
characterized by an intense fluoresce at 750–900 nm, where tis-
sues are most transparent, and a large Stokes shift, offering oppor-
tunities for photodiagnosis and for their use as sensors. Needless to
say, the development of NIR-absorbing materials for therapy and
diagnosis may have a large impact on health care. Ongoing
research in this area may lead not only to the use of novel com-
pounds with increased performance in currently available treat-
ments but also to the discovery of innovative therapeutic
approaches.
Novel stable bacteriochlorins and their metal complexes are
constantly and comprehensively characterized by advanced spec-
troscopic, photophysical, photochemical, electrochemical, and bio-
chemical techniques. Hybrid materials obtained as a result of their
combination with semiconductors and other nanostructures offer
new interesting photochemical, photophysical, and redox proper-
ties. Smart control of these features is possible by the choice of
proper metal, ligand modification, supramolecular architecture
and anchored nanoparticles. Clearly, stable (metallo)bacteriochlo-
rins have opened a new window to the NIR region of the electro-
magnetic spectrum, which has never before been so widely
exploited in chemistry, biology, medicine and industry.
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[92] D. Zigmantas, E.L. Read, T. Mančal, T. Brixner, A.T. Gardiner, R.J. Cogdell, G.R.
Fleming, Two-dimensional electronic spectroscopy of the B800–B820 light-
harvesting complex, Proc. Natl. Acad. Sci. 103 (2006) 12672–12677.
[93] G.S. Schlau-Cohen, E. De Re, R.J. Cogdell, G.R. Fleming, Determination of
excited-state energies and dynamics in the B band of the bacterial reaction
center with 2D electronic spectroscopy, J. Phys. Chem. Lett. 3 (2012) 2487–
2492.[94] A. Konar, R. Sechrist, Y. Song, V.R. Policht, P.D. Laible, D.F. Bocian, D. Holten, C.
Kirmaier, J.P. Ogilvie, Electronic interactions in the bacterial reaction center
revealed by two-color 2D electronic spectroscopy, J. Phys. Chem. Lett. 9
(2018) 5219–5225.
[95] N.S. Ginsberg, Y.-C. Cheng, G.R. Fleming, Two-dimensional electronic
spectroscopy of molecular aggregates, Acc. Chem. Res. 42 (2009) 1352–1363.
[96] M.J. Guberman-Pfeffer, R.F. Lalisse, N. Hewage, C. Brückner, J.A. Gascón,
Origins of the electronic modulations of bacterio-and isobacteriodilactone
regioisomers, J. Phys. Chem. A 123 (2019) 7470–7485.
[97] D. Rutkowska-Zbik, M. Witko, Metallobacteriochlorophylls as potential dual
agents for photodynamic therapy and chemotherapy, J. Mol. Model. 19 (2013)
4155–4161.
[98] Y. Chen, A. Graham, W. Potter, J. Morgan, L. Vaughan, D.A. Bellnier, B.W.
Henderson, A. Oseroff, T.J. Dougherty, R.K. Pandey, Bacteriopurpurinimides:
highly stable and potent photosensitizers for photodynamic therapy, J. Med.
Chem. 45 (2002) 255–258.
[99] Y. Chen, W.R. Potter, J.R. Missert, J. Morgan, R.K. Pandey, Comparative in vitro
and in vivo studies on long-wavelength photosensitizers derived from
bacteriopurpurinimide and bacteriochlorin p6: fused imide ring enhances
the in vivo PDT efficacy, Bioconjug. Chem. 18 (2007) 1460–1473.
[100] A. Kozyrev, M. Ethirajan, P. Chen, K. Ohkubo, B.C. Robinson, K.M. Barkigia, S.
Fukuzumi, K.M. Kadish, R.K. Pandey, Synthesis, photophysical and
electrochemistry of near-IR absorbing bacteriochlorins related to
bacteriochlorophyll a, J. Org. Chem. 77 (2012) 10260–10271.
[101] C. Saenz, R.R. Cheruku, T.Y. Ohulchanskyy, P. Joshi, W.A. Tabaczynski, J.R.
Missert, Y. Chen, P. Pera, E. Tracy, A. Marko, Structural and epimeric isomers
of HPPH [3-devinyl 3-{1-(1-hexyloxy) ethyl} pyropheophorbide-a]: effects on
uptake and photodynamic therapy of cancer, ACS Chem. Biol. 12 (2017) 933–
946.
[102] K. Ohkubo, H. Imahori, J. Shao, Z. Ou, K.M. Kadish, Y. Chen, G. Zheng, R.K.
Pandey, M. Fujitsuka, O. Ito, Small reorganization energy of intramolecular
electron transfer in fullerene-based dyads with short linkage, J. Phys. Chem. A
106 (2002) 10991–10998.
[103] S. Fukuzumi, K. Ohkubo, Y. Chen, R.K. Pandey, R. Zhan, J. Shao, K.M. Kadish,
Photophysical and electrochemical properties of new bacteriochlorins and
characterization of radical cation and radical anion species, J. Phys. Chem. A
106 (2002) 5105–5113.
[104] A. Rosenfeld, J. Morgan, L.N. Goswami, T. Ohulchanskyy, X. Zheng, P.N. Prasad,
A. Oseroff, R.K. Pandey, Photosensitizers derived from 132-oxo-methyl
pyropheophorbide-a: enhanced effect of indium (III) as a central metal in
in vitro and in vivo photosensitizing efficacy, Photochem. Photobiol. 82
(2006) 626–634.
[105] I. Ashur, R. Goldschmidt, I. Pinkas, Y. Salomon, G. Szewczyk, T. Sarna, A.
Scherz, Photocatalytic generation of oxygen radicals by the water-soluble
bacteriochlorophyll derivative WST11, noncovalently bound to serum
albumin, J. Phys. Chem. A 113 (2009) 8027–8037.
[106] C. Brückner, L. Samankumara, J. Ogikubo, Syntheses of bacteriochlorins and
isobacteriochlorins, Handbook Porphyrin Sci. 17 (2012) 1–112.
[107] S. Schreiber, S. Gross, A. Brandis, A. Harmelin, V. Rosenbach-Belkin, A. Scherz,
Y. Salomon, Local photodynamic therapy (PDT) of rat C6 glioma xenografts
with Pd-bacteriopheophorbide leads to decreased metastases and increase of
animal cure compared with surgery, Int. J. Cancer 99 (2002) 279–285.
[108] A. Brandis, O. Mazor, E. Neumark, V. Rosenbach-Belkin, Y. Salomon, A. Scherz,
Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted
photodynamic therapy: synthesis, solubility, phototoxicity and the effect of
serum proteins, Photochem. Photobiol. 81 (2005) 983–992.
[109] N.V. Koudinova, J.H. Pinthus, A. Brandis, O. Brenner, P. Bendel, J. Ramon, Z.
Eshhar, A. Scherz, Y. Salomon, Photodynamic therapy with Pd-
bacteriopheophorbide (TOOKAD): successful in vivo treatment of human
prostatic small cell carcinoma xenografts, Int. J. Cancer 104 (2003) 782–789.
[110] O. Mazor, A. Brandis, V. Plaks, E. Neumark, V. Rosenbach-Belkin, Y. Salomon,
A. Scherz, WST11, a novel water-soluble bacteriochlorophyll derivative;
cellular uptake, pharmacokinetics, biodistribution and vascular-targeted
photodynamic activity using melanoma tumors as a model, Photochem.
Photobiol. 81 (2005) 342–351.
[111] Y. Vakrat-Haglili, L. Weiner, V. Brumfeld, A. Brandis, Y. Salomon, B. Mcllroy, B.
C. Wilson, A. Pawlak, M. Rozanowska, T. Sarna, The microenvironment effect
on the generation of reactive oxygen species by Pd-bacteriopheophorbide, J.
Am. Chem. Soc. 127 (2005) 6487–6497.
[112] M. Kobayashi, E.J. van de Meent, C. Erkelens, J. Amesz, I. Ikegami, T.
Watanabe, Bacteriochlorophyll g epimer as a possible reaction center
component of heliobacteria, Biochim. Biophys. Acta 1057 (1991) 89–96.
[113] H. Tamiaki, S. Yagai, T. Miyatake, Synthetic zinc tetrapyrroles complexing
with pyridine as a single axial ligand, Bioorg. Med. Chem. 6 (1998) 2171–
2178.
[114] A. Osuka, S. Nakajima, K. Maruyama, N. Mataga, T. Asahi, I. Yamazaki, Y.
Nishimura, T. Ohno, K. Nozaki, 1, 2-Phenylene-bridged diporphyrin linked
with porphyrin monomer and pyromellitimide as a model for a
photosynthetic reaction center: synthesis and photoinduced charge
separation, J. Am. Chem. Soc. 115 (1993) 4577–4589.
[115] M.R. Wasielewski, M.P. Niemczyk, Photoinduced electron transfer in meso-
triphenyltriptycenylporphyrin-quinones. Restricting donor-acceptor
distances and orientations, J. Am. Chem. Soc. 106 (1984) 5043–5045.
[116] H. Tamiaki, M. Amakawa, Y. Shimono, R. Tanikaga, A.R. Holzwarth, K.
Schaffner, Synthetic zinc and magnesium chlorin aggregates as models for
B. Pucelik et al. / Coordination Chemistry Reviews 416 (2020) 213340 43supramolecular antenna complexes in chlorosomes of green photosynthetic
bacteria, Photochem. Photobiol. 63 (1996) 92–99.
[117] H. Tamiaki, T. Miyatake, R. Tanikaga, A.R. Holzwarth, K. Schaffner, Self-
assembly of an artificial light-harvesting antenna: energy transfer from a zinc
chlorin to a bacteriochlorin in a supramolecular aggregate, Angew. Chem.,
Int. Ed. Engl. 35 (1996) 772–774.
[118] N. Wakao, N. Yokoi, N. Isoyama, A. Hiraishi, K. Shimada, M. Kobayashi, H. Kise,
M. Iwaki, S. Itoh, S. Takaichi, Discovery of natural photosynthesis using Zn-
containing bacteriochlorophyll in an aerobic bacterium Acidiphilium rubrum,
Plant Cell Physiol. 37 (1996) 889–893.
[119] T. Tomi, Y. Shibata, Y. Ikeda, S. Taniguchi, C. Haik, N. Mataga, K. Shimada, S.
Itoh, Energy and electron transfer in the photosynthetic reaction center
complex of Acidiphilium rubrum containing Zn-bacteriochlorophyll a studied
by femtosecond up-conversion spectroscopy, Biochim. Biophys. Acta 1767
(2007) 22–30.
[120] R. Guilard, K.M. Kadish, K.M. Smith, R. Guilard, The Porphyrin Handbook,
Academic Press, New York, 2003.
[121] T. Miyatake, H. Tamiaki, A.R. Holzwarth, K. Schaffner, Artificial light-
harvesting antennae: Singlet excitation energy transfer from zinc chlorin
aggregate to bacteriochlorin in homogeneous hexane solution, Photochem.
Photobiol. 69 (1999) 448–456.
[122] H. Tamiaki, Self-aggregates of natural and modified chlorophylls as
photosynthetic light-harvesting antenna systems: substituent effect on the
B-ring, Photochem. Photobiol. Sci. 4 (2005) 675–680.
[123] H. Tamiaki, K. Nishihara, R. Shibata, Synthesis of self-aggregative zinc
chlorophylls possessing polymerizable esters as a atable model compound
for main light-harvesting antennas of green photosynthetic bacteria, Int. J.
Photoenergy 2006 (2006).
[124] H. Tamiaki, K. Fukai, H. Shimazu, S. Shoji, Synthesis of zinc chlorophyll homo/
hetero-dyads and their folded conformers with porphyrin, chlorin, and
bacteriochlorin p-systems, Photochem. Photobiol. 90 (2014) 121–128.
[125] G.K. Lahiri, A.M. Stolzenberg, F430 model chemistry. evidence for alkyl-and
hydrido-nickel intermediates in the reactions of the nickel (I)
octaethylisobacteriochlorin anion, Inorg. Chem. 32 (1993) 4409–4413.
[126] A.M. Stolzenberg, L.J. Schussel, J.S. Summers, B.M. Foxman, J.L. Petersen,
Structures of the homologous series of square-planar metallotetrapyrroles
palladium (II) octaethylporphyrin, palladium (II) trans-octaethylchlorin, and
palladium (II) tct-octaethylisobacteriochlorin, Inorg. Chem. 31 (1992) 1678–
1686.
[127] A.M. Stolzenberg, L.J. Schussel, Synthesis, characterization, and
electrochemistry of copper (II) and palladium (II) hydroporphyrins: the
copper (I) octaethylisobacteriochlorin anion, Inorg. Chem. 30 (1991) 3205–
3213.
[128] L. Fiedor, D. Leupold, K. Teuchner, B. Voigt, C.N. Hunter, A. Scherz, H. Scheer,
Excitation trap approach to analyze size and pigmentpigment coupling:
reconstitution of LH1 antenna of rhodobacter sphaeroides with Ni-
substituted bacteriochlorophyll, Biochemistry 40 (2001) 3737–3747.
[129] E. Yang, J.R. Diers, Y.Y. Huang, M.R. Hamblin, J.S. Lindsey, D.F. Bocian, D.
Holten, Molecular electronic tuning of photosensitizers to enhance
photodynamic therapy: synthetic dicyanobacteriochlorins as a case study,
Photochem. Photobiol. 89 (2013) 605–618.
[130] P. Mroz, J. Bhaumik, D.K. Dogutan, Z. Aly, Z. Kamal, L. Khalid, H.L. Kee, D.F.
Bocian, D. Holten, J.S. Lindsey, Imidazole metalloporphyrins as
photosensitizers for photodynamic therapy: role of molecular charge,
central metal and hydroxyl radical production, Cancer Lett. 282 (2009) 63–
76.
[131] L.G. Arnaut, Design of porphyrin-based photosensitizers for photodynamic
therapy, Adv. Inorg. Chem. Elsevier (2011) 187–233.
[132] P. Mroz, A. Yaroslavsky, G.B. Kharkwal, M.R. Hamblin, Cell death pathways in
photodynamic therapy of cancer, Cancers 3 (2011) 2516–2539.
[133] Y. Posen, V. Kalchenko, R. Seger, A. Brandis, A. Scherz, Y. Salomon,
Manipulation of redox signaling in mammalian cells enabled by controlled
photogeneration of reactive oxygen species, J. Cell Sci. 118 (2005) 1957–
1969.
[134] J.W. Springer, K.M. Faries, J.R. Diers, C. Muthiah, O. Mass, H.L. Kee, C. Kirmaier,
J.S. Lindsey, D.F. Bocian, D. Holten, Effects of substituents on synthetic
analogs of chlorophylls. Part 3: the distinctive impact of auxochromes at the
7-versus 3-positions, Photochem. Photobiol. 88 (2012) 651–674.
[135] H.L. Kee, C. Kirmaier, Q. Tang, J.R. Diers, C. Muthiah, M. Taniguchi, J.K. Laha, M.
Ptaszek, J.S. Lindsey, D.F. Bocian, Effects of substituents on synthetic analogs
of chlorophylls. Part 1: synthesis, vibrational properties and excited-state
decay characteristics, Photochem. Photobiol. 83 (2007) 1110–1124.
[136] H.L. Kee, C. Kirmaier, Q. Tang, J.R. Diers, C. Muthiah, M. Taniguchi, J.K. Laha, M.
Ptaszek, J.S. Lindsey, D.F. Bocian, Effects of substituents on synthetic analogs
of chlorophylls. Part 2: redox properties, optical spectra and electronic
structure, Photochem. Photobiol. 83 (2007) 1125–1143.
[137] O. Mass, M. Taniguchi, M. Ptaszek, J.W. Springer, K.M. Faries, J.R. Diers, D.F.
Bocian, D. Holten, J.S. Lindsey, Structural characteristics that make
chlorophylls green: interplay of hydrocarbon skeleton and substituents,
New J. Chem. 35 (2011) 76–88.
[138] L. Petit, C. Adamo, N. Russo, Absorption spectra of first-row transition metal
complexes of bacteriochlorins: a theoretical analysis, J. Phys. Chem. B 109
(2005) 12214–12221.
[139] M.J. Guberman-Pfeffer, J.A. Greco, L.P. Samankumara, M. Zeller, R.R. Birge, J.A.
Gascón, C. Brückner, Bacteriochlorins with a twist: discovery of a uniquemechanism to red-shift the optical spectra of bacteriochlorins, J. Am. Chem.
Soc. 139 (2016) 548–560.
[140] A.V. Simoes, A. Adamowicz, J.M. Dąbrowski, M.J. Calvete, A.R. Abreu, G.
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biodistribution, pharmacokinetics and photodynamic efficacy using a new
photostable sulfonamide bacteriochlorin, MedChemComm 3 (2012) 502–
505.
[159] C. Serpa, J. Schabauer, A.P. Piedade, C.J. Monteiro, M.M. Pereira, P. Douglas, H.
D. Burrows, L.G. Arnaut, Photoacoustic measurement of electron injection
efficiencies and energies from excited sensitizer dyes into nanocrystalline
TiO2 films, J. Am. Chem. Soc. 130 (2008) 8876–8877.
[160] M. Pineiro, A.L. Carvalho, M.M. Pereira, A.D.A.R. Gonsalves, L.G. Arnaut, S.J.
Formosinho, Photoacoustic measurements of porphyrin triplet-state
quantum yields and singlet-oxygen efficiencies, Chem. Eur. J. 4 (1998)
2299–2307.
[161] G.F. Sá, C. Serpa, L.G. Arnaut, Stratum corneum permeabilization with
photoacoustic waves generated by piezophotonic materials, J. Control.
Release 167 (2013) 290–300.
[162] F.A. Schaberle, A.R. Abreu, N.P. Gonçalves, G.A.F. Sá, M.M. Pereira, L.G. Arnaut,
Ultrafast dynamics of manganese (III), manganese (II), and free-base
bacteriochlorin: is there time for photochemistry?, Inorg Chem. 56 (2017)
2677–2689.
44 B. Pucelik et al. / Coordination Chemistry Reviews 416 (2020) 213340[163] A. Franke, A. Scheitler, I. Kenkel, R. Lippert, A. Zahl, D. Balbinot, N. Jux, I.
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